Key Highlights

Business and Strategy Update

Mastek Limited has announced the expansion of its Trichy office. The facility is designed to support the company’s growing technology teams, acting as a hub for both service delivery and innovation. The expansion adds capacity for 150–200 professionals and brings together teams across critical digital service lines, specifically Salesforce, Oracle, and Data & AI.

Management stated that the expansion is an integral step in the company's strategy to build technology capabilities closer to emerging talent ecosystems. CEO Umang Nahata noted that the region holds significant potential as enterprises accelerate their adoption of AI, data, and cloud-led transformation.

Talent and Community Engagement

A core objective of the expansion is to tap into the talent pool emerging from regional colleges and educational institutions. Mastek plans to:

• Deepen Academic Ties: Implement technology-focused engagement programs, including "Deep Blue Sessions" for final-year students and dedicated AI-specific sessions to provide real-world exposure.
• Community Support: Coordinate with local NGOs through the Mastek Foundation to identify opportunities for community engagement and social impact, allowing employees to contribute to local needs.

What Looks Positive

• Talent Access: Proactive engagement with educational institutions creates a pipeline of future-ready talent in the region.
• Capability Alignment: The centre is specifically focused on high-demand service lines (Salesforce, Oracle, AI), which aligns with the company's broader "Lead with AI" business approach.

Concerns and Watch Points

• Scaling and Utilization: Investors should track the company’s progress in hiring and effectively utilizing the additional 150–200 headcount capacity at this location.

Investor Takeaway

This expansion represents a localized growth initiative aimed at strengthening delivery and talent sourcing. While it does not indicate immediate financial shifts, it reflects the company’s strategy of building regional infrastructure to support its global digital and AI service offerings.

Key Highlights

Financial Snapshot

The company reported revenue of $107.3 million, up 2.4% sequentially in constant currency. In INR terms, revenue stood at Rs 1,018.7 crore, up 3.4% QoQ and 8.3% YoY. EBITDA margin was 14.4%, representing a 100-basis point sequential decline. Management explained that salary increments and ESOPs caused a 190-bps impact, partially offset by AI-led productivity efficiencies.

Profitability and Margin Analysis

Management emphasized that the margin drop was primary due to a 190-bps impact from increments and ESOPs, coupled with a mix change where high-margin projects were replaced by lower-margin ones in the UK. The company is targeting a recovery of at least 160 bps in the medium term, contingent upon geopolitical factors and macro conditions.

Business and Operational Updates

• AI Transformation: The company is pivoting toward an 'AI-native' organization. AI deals comprised over 40% of the total deal flow in the quarter.
• Geographical Performance: The UK market delivered 4.1% revenue growth, with strong performance in Financial Services (up 16% YoY). However, order book softness was noted in the UK due to political transitions and policy re-evaluations. The North America business saw a 50%+ YoY backlog growth, and management expects a meaningful turnaround in growth from H2. The Middle East remains uncertain.
• Energy and Utilities: Mastek has entered this space by landing three new frameworks and is targeting organizations that operate like private entities but purchase through public-sector-like processes.

Strategic Developments

• Partnerships: Mastek signed a strategic partnership with Innovaccer to leverage contextual data for Healthcare & Life Sciences AI transformation.
• New Offering: The company launched a 'Service-as-a-software' offering, which management is also using internally for CRM, procurement, and recruitment systems.

Management Commentary and Guidance

Management expressed confidence in FY27 outperforming FY26, despite current geopolitical and macroeconomic headwinds. The company is currently bidding for large deals in the UK (some exceeding 100 million pounds). The transition to an AI-native model is expected to create long-term value, with small entry-level AI projects evolving into larger, repeatable engagements.

Concerns and Watch Points

• Order Book Softness: 12-month backlog declined 7.7% sequentially, driven by deferred project starts and slower consumption in North America (federal government election impact) and the UK.
• Geopolitical Risks: The Middle East market performance remains a concern due to ongoing uncertainties.
• Margin Volatility: Sustaining margins remains a primary focus, with the company needing to navigate localization and security-cleared resource requirements in the UK, which may impact subcon costs.

Earnings Conference Call Recording

Mastek Ltd has formally submitted the audio recording of its earnings conference call held on October 26, 2026, to the stock exchanges. The call addressed the company's unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.

These financial results were previously reviewed and approved by the company's Board of Directors during their meeting on October 23, 2026.

Access to Recording

Investors and stakeholders can access the audio recording of the earnings call via the company's official website using the link provided in the regulatory filing. This allows market participants to review the management's commentary and insights provided during the interaction with analysts and investors.

Publication Details

On October 24, 2026, Mastek Ltd informed the BSE and NSE that it had published its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026, in various newspapers. The filing confirms the company's adherence to disclosure norms.

Newspaper Advertisements

The financial results extract was published in the following editions on October 24, 2026:

• The Financial Express (English, Mumbai edition)
• The Financial Express (Gujarati, Ahmedabad edition)
• Mumbai Lakshadweep (Marathi, Mumbai edition)

Regulatory Context

This disclosure complies with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates that listed entities publish key financial information in widely circulated newspapers to ensure transparency and accessibility for all stakeholders.

What Shareholders Should Know

This is a routine compliance notice. The full financial results and related disclosures are available on the company’s website at www.mastek.com and the respective stock exchange platforms (BSE/NSE). No specific action is required from shareholders.

Key Highlights

Financial Summary

In the quarter ended September 30, 2026, Mastek achieved revenue of Rs 1,018.7 crore. Operating EBITDA margin was reported at 14.4%, a decline of 109 basis points sequentially, which management attributed to the impact of annual salary increments. Net Profit stood at Rs 105.7 crore, effectively flat compared to the previous quarter but up 8.4% compared to Q2FY26.

Order Backlog and AI Strategy

The 12-month order backlog reached Rs 2,742.8 crore, showing a 10.4% growth on a year-on-year basis. A significant strategic shift is underway, with the company signing 53 new AI-focused deals during the quarter, which now contribute approximately 45% of the overall order book. Mastek has also formed a strategic partnership with Innovaccer to enhance its data and AI capabilities within the healthcare and life sciences verticals.

Operating Performance

• Employees: The company reported a total headcount of 4,810, representing a net reduction of 87 employees during the quarter.
• Attrition: Last twelve months (LTM) attrition improved to 15.2% from 16.4% in the previous quarter.
• Cash Position: Total cash, cash equivalents, and investments were Rs 930.6 crore, compared to Rs 945.4 crore as of June 30, 2026. The company noted that Rs 37 crore was added to net cash during the quarter after accounting for a dividend payout of ~Rs 50 crore and loan repayments of ~Rs 55 crore.

Segment Highlights

• Geography: UK & Europe remains the primary contributor at 67.8% of revenue, followed by the US at 21.2% and AMEA at 11.0%.
• Industry: Financial Services is the leading vertical at 44.4% of revenue, while Government & Education contributes 16.9%.

Management Commentary

Management indicated that the company is transitioning toward being an AI-native organization. The UK and Europe business delivered 4.1% sequential revenue growth in rupee terms. While the North American business showed positive momentum, the Middle East (AMEA) region continues to be impacted by geopolitical uncertainties. Management emphasized a continued focus on operational efficiency and disciplined cost management to counter the margin impact of annual increments.

Concerns and Watch Points

• Margin Pressure: The Operating EBITDA margin contraction is a primary watch point; investors should monitor whether the AI-led productivity measures can effectively offset wage-related cost pressures in future quarters.
• Geopolitical Risks: The company explicitly stated that its AMEA operations continue to face challenges from geopolitical uncertainties.

Key Highlights

Financial Snapshot

Mastek reported a consolidated revenue of Rs 1,018.7 crore for the quarter ended September 30, 2026, an increase of 3.4% sequentially and 8.3% year-on-year. The operating EBITDA was Rs 146.2 crore, with a margin of 14.4%. The company noted that margins were impacted by annual increment cycles. Net profit for the quarter stood at Rs 105.7 crore, marginally lower by 0.2% QoQ but higher by 8.4% YoY.

Business and Operational Performance

Mastek continues to push its 'Lead with AI' strategy, reporting 53 new AI-related deal wins during the quarter, which contributed to approximately 45% of the total order book. The company highlighted:

• Order Backlog: The 12-month order backlog was Rs 2,742.8 crore ($286.2 million), representing 10.4% YoY growth in rupee terms.
• Strategic Wins: Notable engagement wins include a Service-as-Software engagement with a US senior care provider and a five-year strategic partnership with a NYSE-listed global dental technology leader.
• Geographical Performance: UK & Europe remains the largest contributor to revenue at 67.8% of the mix, reporting 4.1% QoQ growth. The company noted that geopolitical uncertainty continues to impact the AMEA region.

Balance Sheet and Cash Flow

The company maintained a healthy cash position, with total cash, cash equivalents, and investments at Rs 930.6 crore as of September 30, 2026. Mastek added Rs 37 crore in net cash during the quarter, even after accounting for dividend payouts of ~Rs 50 crore and loan repayments of ~Rs 55 crore.

Management Commentary

Management stated that the company is evolving into an AI-native organization, with its AI-led solutions gaining traction. While the Middle East continues to face geopolitical challenges, the overall long-term outlook remains positive, supported by growth in the Data and AI business. Operational efficiency and cost management remain key focus areas as the company works to mitigate margin pressure.

Concerns and Watch Points

• Margin Pressure: Operating EBITDA margins have seen consecutive quarterly compression (15.4% in Q1FY27 vs 14.4% in Q2FY27), largely driven by employee cost increments.
• Geopolitical Risk: The AMEA region continues to face headwinds from geopolitical uncertainties.
• Employee Base: The company saw a net reduction of 87 employees during the quarter, bringing the total headcount to 4,810.

Investor Takeaway

Mastek’s results indicate steady business execution with revenue growth and strong AI-focused order intake. The primary concern for shareholders to monitor is the sustainability of margins amid rising costs and the impact of geopolitical challenges in the AMEA region on overall profitability.

Consolidated Financial Results (Q2 FY27)

The company reported consolidated revenue from operations of Rs 1,018.68 crore (101,868 lakh) for the quarter ended September 30, 2026, compared to Rs 985.25 crore (98,525 lakh) in the previous quarter. Net profit attributable to owners of the company was Rs 105.67 crore (10,567 lakh), compared to Rs 105.88 crore (10,588 lakh) in the quarter ended June 30, 2026.

Financial Snapshot (Consolidated)

Exceptional Items

The consolidated financial results for the quarter ended September 30, 2026, include a net exceptional gain of Rs 10.72 crore (1,072 lakh), detailed as follows:

Segment Performance (Consolidated)

The company manages performance based on geographical location. The UK & Europe operations remained the largest revenue contributor.

• UK & Europe operations: Revenue of Rs 691.24 crore in Q2 FY27 vs. Rs 663.71 crore in Q1 FY27.
• North America operations: Revenue of Rs 215.56 crore in Q2 FY27 vs. Rs 213.54 crore in Q1 FY27.
• AMEA: Revenue of Rs 111.88 crore in Q2 FY27 vs. Rs 108.00 crore in Q1 FY27.

Dividend Update

The company declared that the final dividend of Rs 16 per share (320% on face value of Rs 5 each), as recommended by the board on April 17, 2026, was approved by shareholders at the AGM held on September 7, 2026, and paid to eligible shareholders on September 18, 2026.

Concerns and Watch Points

• Exceptional Items: The performance in the current quarter included a one-time gain from property disposal, which was partially offset by restructuring costs and significant bad debt write-offs of Rs 25.90 crore (2,590 lakh).
• Operating Margins: Total expenses rose to Rs 899.66 crore in Q2 FY27 from Rs 858.82 crore in the previous quarter, with employee benefit expenses remaining the primary cost driver at Rs 548.05 crore.

What This Means for Investors

Investors should monitor the company's core operational growth as the reported net profit remained relatively flat sequentially despite the property-sale gain. The management is currently implementing AI-led operational efficiency initiatives, for which restructuring costs were incurred.

Key Highlights

Mastek Ltd announced its unaudited financial results for the quarter and six months ended September 30, 2026. The results are characterized by moderate revenue growth and significant exceptional items that affected the consolidated net profit.

Important Figures (Consolidated)

Financial Snapshot

The company reported consolidated revenue of Rs 1,018.68 crore for the quarter, up from Rs 940.37 crore in the same period last year. Net profit stood at Rs 105.67 crore for the quarter, compared to Rs 97.45 crore in the year-ago quarter. For the six months ended September 30, 2026, revenue was Rs 2,003.93 crore and net profit was Rs 211.55 crore.

Exceptional Items Analysis

The consolidated results include net exceptional items of Rs 10.72 crore, which stem from several non-recurring factors:

• Gain on Property Sale: Recognized a gain of Rs 47.26 crore from the sale of property, plant, and equipment in Chennai.
• Restructuring Costs: Incurred one-time costs of Rs 10.64 crore to improve AI-led operational efficiency.
• Bad Debts Written Off: The company wrote off collectables and unbilled amounts totaling Rs 25.90 crore, attributed to AMEA (Rs 9.09 crore) and US (Rs 16.81 crore) geographies.

Segment Performance (Revenue)

Governance and Corporate Updates

• Equity Capital: The paid-up equity share capital increased by Rs 0.0045 crore (0.45 lakhs) following the allotment of 9,036 equity shares to employees exercising ESOP options.
• Audit Review: The financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors on October 23, 2026. M/s. Walker Chandiok & Co. LLP issued a limited review report.

What This Means for Investors

The consolidated figures demonstrate steady year-over-year revenue growth. However, shareholders should distinguish between the core operational performance and the impact of the one-time exceptional items. The property sale provided a significant boost, while the restructuring costs and bad debt write-offs reflect operational realignment and clean-up efforts. Monitoring the impact of these restructuring efforts on future operating margins will be key.

Investor Takeaway

Existing shareholders should note the consolidated results reflect a mix of growth and transition-related costs. While revenue and net profit grew on a year-on-year basis, the reported earnings were materially influenced by non-recurring events. The focus in coming quarters should remain on core revenue sustainability and whether the restructuring initiatives yield the intended operational efficiencies.

Investor Interaction Schedule

Mastek Limited has formally intimated the exchanges regarding a scheduled Non-Deal Roadshow (NDR) for institutional investors.

Nature of Discussions

Management representatives will conduct one-on-one and group meetings with investors. The company has explicitly stated that the discussions will be limited to industry and company-specific developments already in the public domain.

No Unpublished Price Sensitive Information (UPSI) is proposed to be shared during these interactions.

Key Highlights

Meeting Details

Mastek Ltd has provided formal intimation to the stock exchanges regarding a scheduled non-deal roadshow. The management team will engage with institutional investors and analysts through a series of one-on-one and group meetings.

The discussions will be strictly limited to information already available in the public domain. The company has clarified that no unpublished price-sensitive information (UPSI) will be discussed or disclosed during these sessions.

Investor Implications

This filing is a routine compliance update under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Investors should view this as a regular communication exercise and not as an event involving new material financial disclosures or strategic announcements.

Conference Call and Earnings Schedule

Mastek Ltd has scheduled its earnings conference call for the second quarter of fiscal year 2027 (Q2FY27) on Monday, October 26, 2026, at 8:00 A.M. (IST). The company plans to release its financial results for the quarter and half-year ended September 30, 2026, on Friday, October 23, 2026.

The earnings call will provide a platform for investors and analysts to discuss the financial performance and the company's business outlook. Interested participants have been provided with dial-in options and a registration link to facilitate access to the event.

Management Representation

The company has confirmed that the following key members of its leadership team will be representing Mastek Group during the conference call:

• Umang Nahata: Chief Executive Officer
• Deepak Kedia: Chief Financial Officer
• Niraj Khemka: Head of IR & FP&A

Participants are requested to dial into the conference call 10 minutes prior to the scheduled start time.

Key Highlights. The Stakeholder Relationship Committee of the Board of Directors approved and allotted 4,454 equity shares under the Employee Stock Option Plan (ESOP). Allotment Date: October 12, 2026. Face Value: Rs 5 per share. Total Issued Share Capital after issue: 3,10,10,830 equity shares. Total Paid-up Value after issue: Rs 15,50,54,150. ### Allotment Details. The 4,454 shares were allotted to eligible employees who exercised their vested options. The exercise prices were: 3,766 shares at Rs 5 per share (Premium: Rs 0), 400 shares at Rs 174 per share (Premium: Rs 169), and 288 shares at Rs 350 per share (Premium: Rs 345). The shares rank pari-passu with the existing equity shares of the company. ### Investor Takeaway. This is a standard corporate filing reflecting the routine execution of employee stock incentive schemes. It does not indicate a material change in company strategy or financial health. Investors should note this as a procedural event involving a minor dilution to the total share capital.

Award Recognition

Mastek Ltd announced it has won the 2026 ISG Paragon Partnership of the Year award for North America, alongside its client, CORT Business Services (a Berkshire Hathaway company). The award, presented on September 24, 2026, honors the decade-long collaboration between the two companies regarding digital and business transformation.

Operational Performance

The announcement highlighted the recent launch of the "CORT Furniture Outlet," a B2C e-commerce platform designed and built by Mastek. The project yielded the following performance metrics within two weeks of launch:

Strategic Roadmap

Building on the existing foundation of managed services, application modernization, and digital engineering, the partnership is transitioning its roadmap toward:

• AI-led business transformation: Embedding AI into customer journeys, operations, and digital commerce to accelerate decision-making.
• Services as Software model: Utilizing AI, automation, and reusable digital capabilities to deliver outcomes with increased speed and scale.

Management Commentary

Management described the relationship as a "strategic partnership" that has evolved from basic application modernization to complex AI-led transformation. The collaboration aims to move beyond traditional technology delivery toward "intelligent, outcome-driven services."

Investor Takeaway

While this award serves as a validation of Mastek's ability to maintain long-term client relationships and deliver measurable operational improvements (as seen in the CORT Furniture Outlet launch), it is a qualitative development. Investors may watch for similar "AI-led" service adoption across the company's broader client base, as management seeks to shift toward the proposed "Services as Software" delivery model.

Project Overview

Mastek (UK) Ltd, a wholly-owned subsidiary of Mastek Ltd, has secured a significant contract with Staffordshire County Council to implement an Oracle Cloud transformation programme. The engagement is part of the Council's broader ambition to modernize its corporate services and establish an agile, digitally enabled operating model.

Strategic Importance

This programme marks a milestone for Mastek's growth within the UK local government sector. The company was selected following a competitive procurement process, based on its Oracle Cloud expertise, extensive experience in the UK local government space, and its AI-native transformation approach.

By deploying its ADOPT-AI platform, Mastek aims to:

• Consolidate legacy systems for the Council.
• Strengthen data governance.
• Enhance the overall employee experience.
• Establish a modern digital foundation for future organizational changes.

Market Context

The win reinforces Mastek's role as a transformation partner for large-scale public sector initiatives. The project is particularly relevant as local authorities across England are preparing for structural reorganisation and are seeking scalable, modern technology platforms to support operational resilience and service delivery.

Management Commentary

Abhishek Singh, President UKI & Europe, Mastek, stated that the company is "delighted to partner with Staffordshire County Council" and noted that local authorities are increasingly focused on modernizing operations for future structural changes. Pete Shakespear, Director of Finance & Resources, Staffordshire County Council, highlighted that Mastek demonstrated a "strong understanding" of the Council's objectives to build a more agile and future-ready organization.

Investor Takeaway

The announcement serves as a positive operational update, confirming Mastek's ability to win competitive, long-term public sector mandates. While no financial value was disclosed, the partnership strengthens the company's reference portfolio for similar enterprise-wide modernization initiatives in the public sector. Shareholders should monitor future disclosures for potential revenue impact or scaling of such engagements.

Board Meeting Details

Mastek Ltd has announced that a meeting of its Board of Directors is scheduled for October 23, 2026. The primary agenda is to consider and approve the company's standalone and consolidated unaudited financial results for the second quarter and half-year ended September 30, 2026.

Trading Window

In compliance with SEBI (Prohibition of Insider Trading) Regulations and the company's internal code, the trading window for Mastek Ltd's securities has been closed since September 30, 2026. The window will reopen on October 26, 2026, which is 48 hours after the financial results are made public.

Earnings Conference Call

The company has scheduled an earnings conference call for investors and analysts on Monday, October 26, 2026, at 8:00 A.M. (IST). This call will cover the financial performance for the period and the company's business outlook. Further details regarding the conference call access will be made available on the company's website in due course.

Compliance Certificate Filing

Mastek Limited has submitted the compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.

The filing confirms that the details of securities dematerialized or rematerialized during the quarter have been duly furnished to the depositories (CDSL and NSDL) and the stock exchanges where the company's shares are listed.

Registrar Confirmation

The company's Registrar and Share Transfer Agent, KFin Technologies Limited, has issued certificates confirming compliance with the regulatory requirements. These certificates were addressed to the Central Depository Services (India) Limited (CDSL) and the National Securities Depository Limited (NSDL), respectively.

This is a standard quarterly procedural requirement and does not imply any change to the company's financial or operational standing.

Key Highlights

Strategy Overview

Mastek Ltd has announced a strategic shift towards a "Services as Software" (SaS) model. The company aims to move beyond providing traditional enterprise software implementation and management, instead offering AI-native services designed to simplify technology landscapes and reduce subscription costs for clients. The strategy is built on three core pillars:

1. Tangible Business Results: Shifting focus from mere usage metrics or deployment milestones to measurable business outcomes.
2. System of Intelligence: Moving from systems that merely report historical information to "systems of intelligence" that connect knowledge and deliver real-time insights.
3. Outcome-Based Pricing/Cost Reduction: Assessing actual software usage to eliminate redundant applications and complexity.

Operational Proof Points

The company has validated this approach using its own internal operations (the "Customer Zero" approach). Mastek developed an AI-native CRM platform that replaced its legacy environment. This internal deployment served to stress-test the platform's scalability, usability, and business impact. The firm is currently targeting a 10% improvement in win probability for its sales team by using contextual data and intelligent forecasting.

Building on this, Mastek is developing an Intelligent Document Processing solution. This tool is designed to replace legacy SAP Procurement, Accounts Payable, and Expense Management applications, aiming for faster, simpler processes and tangible cost optimization.

Management Commentary

Management emphasized that this strategy is not a pivot toward becoming a software product company. Instead, Mastek remains committed to a services-led model where deep domain expertise, AI, data, and engineering converge.

CEO Umang Nahata noted that applying AI to accelerate old ways of working is insufficient; organizations must reimagine processes and reskill talent. CTIO Ritwik Batabyal highlighted the use of "Mastek Hub," a centralized knowledge platform combining project experience, proposal assets, and business intelligence to drive AI-based decision-making and automate the capture of institutional knowledge.

What This Means for Investors

This announcement signals Mastek’s attempt to increase the value-add of its service offerings by embedding proprietary AI solutions. For investors, the success of this strategy will depend on the company's ability to transition from a traditional service-provider model to one where it can capture additional value by directly optimizing client costs and business processes. The primary monitorable will be the adoption rate of these SaS solutions among existing and new clients.

Investor Takeaway

Mastek’s strategy aims to increase service stickiness and differentiation by directly linking its service delivery to client cost reduction and AI-driven outcomes. While the initial proof-of-concept (internal CRM) is operational, the key watch point is the external scalability of these AI-native solutions and whether they result in higher margins or expanded market share in a competitive IT services landscape.

Investor Meeting Notification

Mastek Ltd (BSE: 523704) has formally notified the stock exchanges regarding a scheduled engagement with an institutional investor. The company intends to conduct an in-person, one-to-one meeting to discuss industry trends and company-specific developments that have already been made public.

Meeting Details

Compliance Statement

The company has confirmed that discussions during this interaction will be based strictly on publicly available information. Mastek Ltd stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during the meeting, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Publication Details

Mastek Limited has published a statutory notice in newspapers regarding the transfer of shares to the Investor Education and Protection Fund (IEPF) Authority. This notice serves as a reminder to shareholders who have failed to claim their dividends for seven or more consecutive years, a condition that mandates the transfer of shares to the IEPF.

Regulatory Context

Pursuant to Section 124 of the Companies Act, 2013, and the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, companies are required to transfer unclaimed dividends and the underlying shares to the IEPF Authority after seven consecutive years of non-payment.

What Shareholders Should Know

Shareholders whose dividends remain unclaimed are at risk of having their shares transferred to the IEPF Authority account. The company has facilitated the process for shareholders to verify their status and claim these amounts before the transfer is executed. If no claim is made by the deadline stipulated by statutory rules, the company is legally obligated to proceed with the transfer of the shares.

Shareholder Instructions

Shareholders are encouraged to:

1. Verify their dividend status on the company's official website.
2. Contact the company's registrar or the Secretarial Department via email at investor_grievances@mastek.com if they identify any unclaimed dividends.
3. Complete the necessary claims process promptly to ensure their shares remain in their respective demat accounts.

Shareholding Update

Mastek Ltd has informed the stock exchanges that Bandhan Mutual Fund has increased its stake in the company. Following an open market acquisition on September 15, 2026, the fund's total shareholding has crossed the 5% mark, triggering a mandatory disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Acquisition Details

The following table summarizes the change in the acquirer's position:

• Acquisition Volume: 18,000 equity shares.
• Date of Acquisition: September 15, 2026.
• Mode of Acquisition: Open Market.

Regulatory Context

As of September 17, 2026, the company's paid-up share capital stands at 3,10,06,376 equity shares of Rs. 5 each. Under SEBI guidelines, entities acquiring or disposing of shares resulting in a change of 2% or more, or crossing the 5% threshold, are required to disclose their shareholding status to the target company and the stock exchanges. This filing serves to maintain transparency regarding substantial holdings in the company's equity capital.

Investor Takeaway

This event is a routine regulatory disclosure concerning institutional shareholding movements. The acquisition by Bandhan Mutual Fund reflects an increase in its portfolio exposure to Mastek Ltd. Existing shareholders should note that this is a standard compliance filing and does not signal a change in the company's management or promoter control.

Disclosure Overview

Bandhan Mutual Fund has submitted a disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, to the BSE. The filing reports an increase in the fund's shareholding in Mastek Limited following an open market transaction conducted on September 15, 2026.

Shareholding Change Details

The table below summarizes the change in Bandhan Mutual Fund's shareholding in Mastek Limited as reported in the disclosure:

Transaction Summary

• Date of Acquisition: September 15, 2026
• Mode of Acquisition: Open Market
• Number of Shares Acquired: 18,000
• Percentage Acquired: 0.0580%

Investor Takeaway

For shareholders, this filing serves as an update on institutional ownership in Mastek Limited. Bandhan Mutual Fund's acquisition of 18,000 shares has pushed its aggregate holding above the 5% mark to 5.0544%. While this is a standard regulatory compliance filing indicating ongoing institutional accumulation, it does not involve a change in control or management strategy. Investors should monitor future shareholding pattern disclosures to determine if this buying trend persists.

Investor Conference Participation

Mastek Ltd has provided a formal intimation to the stock exchanges regarding its participation in an upcoming investor conference. The company's officials are scheduled to attend the 'Anand Rathi G-200 Summit 2026: Bharat – The Next Engine of Global Growth' on September 22, 2026.

Event Details

Discussion Scope

The company has clarified that the discussions during the conference will be limited to industry and company-specific developments that are already in the public domain. Mastek Ltd has explicitly stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during the event.

Key Highlights

• Event: 44th Annual General Meeting (AGM)
• Date: September 7, 2026
• Platform: Video Conferencing (VC) / Other Audio Visual Means (OAVM)
• Outcome: All three ordinary resolutions passed with the requisite majority.

Agenda and Results

Shareholders voted on the following resolutions:

1. Adoption of Financial Statements: The Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, were adopted.
2. Dividend Confirmation: The interim dividend payment and the declaration of the final dividend for the financial year 2025-26 were confirmed.
3. Director Appointment: The re-appointment of Mr. Umang Nahata (DIN: 00323145) as a Director liable to retire by rotation was approved.

Meeting Attendance

The meeting commenced at 5:00 p.m. and concluded at 5:57 p.m., with an additional 15 minutes allowed for e-voting. A total of 42 shareholders attended the meeting via video conferencing (18 from the Promoter/Promoter Group and 24 from the Public category).

Investor Takeaway

This filing formalizes the successful conclusion of the 44th AGM. Shareholders and market observers can note the ratification of the financial results for the 2025-26 fiscal year and the formal confirmation of dividend payouts. The governance-related approval of the board rotation is in line with standard regulatory procedures.

Key Highlights

Agenda Items

The company presented the following items for shareholder approval via ordinary resolutions:

• Financial Adoption: Adoption of the standalone and consolidated audited financial statements for the financial year ended March 31, 2026.
• Dividend Confirmation: Confirmation of the interim dividend of Rs 8.00 per equity share and declaration of a final dividend of Rs 16.00 per equity share for the financial year 2025-26.
• Director Re-appointment: Re-appointment of Mr. Umang Nahata as a Director liable to retire by rotation.

Management Commentary and Q&A

Chairman Ashank Desai and CEO Umang Nahata addressed members, providing an overview of the company's performance during the financial year and broader industry trends. The management engaged in a Q&A session with shareholders, covering topics such as:

• Company strategy and future roadmap.
• Financial performance.
• Integration and impact of Artificial Intelligence (AI).
• Impact of geopolitical issues on operations.

Investor Takeaway

This filing confirms the successful convening of the 44th AGM. The business transacted was standard for an annual meeting, focusing on financial compliance, dividend payouts, and board governance. Shareholders should monitor the upcoming separate filing for the official voting results on these resolutions.

Board and Governance Update

Mastek Limited has formally reported the cessation of Ms. Marilyn Jones as an Independent Director of the company.

Key Details

The company confirmed that this change is effective from the close of business hours on September 04, 2026. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board has placed on record its appreciation for her contributions and services during her tenure.

Investor Meet Details

Mastek Ltd has announced an upcoming one-to-one meeting with an institutional investor representative, as part of its ongoing investor relations activity.

Disclosure Standards

The company has explicitly stated that all discussions during this interaction will be based solely on publicly available information. Mastek Ltd confirmed that no unpublished price-sensitive information (UPSI) is proposed to be shared with the participant. This intimation is provided in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Corporate Action Details

Mastek Ltd. has formally announced the allotment of 3,969 equity shares under the company's Employee Stock Option Plan (ESOP). The Stakeholder’s Relationship Committee of the Board of Directors approved this allotment for eligible employees who exercised their vested options.

Key terms of the issuance include:

• Instrument: Equity Shares
• Face Value: Rs. 5 per share
• Exercise Price: Rs. 5 per share
• Scheme: ESOP Plan VII

The company confirmed that the newly allotted shares rank pari-passu with the existing equity shares in all respects.

Capital Structure Update

Following this allotment, the paid-up share capital of the company has seen a minor increase:

Investor Takeaway

This announcement is a routine procedural filing compliant with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Regulation 10(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014. The issuance of 3,969 shares represents a negligible portion of the total equity base and does not materially alter the company's financial position or shareholder structure.

Investor Meeting Schedule

Mastek Limited has announced its participation in the 'Ashwamedh - Elara India Dialogue 2026' investor conference. The company has provided the following schedule details:

Regulatory Compliance

The company has confirmed that discussions at the event will be strictly limited to industry and company-specific developments that are already in the public domain. Mastek Limited has explicitly stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during this meeting, ensuring adherence to SEBI (Listing Obligations and Disclosure Requirements) regulations.

Investor Meeting Schedule

Mastek Ltd has issued a formal intimation regarding a Non-Deal Roadshow (NDR) involving its management representatives. The event is scheduled to take place on August 26, 2026.

Meeting Details

Governance and Compliance

The company has clarified that the discussions during this roadshow will be strictly limited to industry and company-specific developments that have already been made available in the public domain. Mastek Ltd has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be shared with the investors or analysts during these interactions.

This filing is in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the disclosure of such investor engagements to ensure transparency.

Transaction Overview

Mastek Ltd has confirmed the successful completion of the sale of a commercial building located at Mahindra World City, SEZ, Chengalpattu, Chennai. The company received an aggregate consideration of Rs. 60 crore for the asset.

Key Transaction Details

Compliance and Regulatory Status

The company clarified that the transaction does not fall under the purview of Related Party Transactions. Furthermore, the sale is not part of any Scheme of Arrangement and does not attract the terms of regulation 37A of the LODR Regulations, as the asset does not constitute substantially the whole of the undertaking under section 180 (1)(a) of the Companies Act, 2013.

Investor Implications

This development concludes the asset sale process initiated by the company in April 2026. The transaction converts the commercial asset into liquid capital, aligning with the company's strategy regarding non-core property holdings. Shareholders should note that the transaction is finalized and carries no further contingent approvals under the current disclosure.

Transaction Overview

Mastek Ltd has announced the completion of the sale of its commercial building located at Mahindra World City, SEZ, Chengalpattu, Chennai. The property includes an approximate built-up area of 1,57,233 sq. ft. situated on 15.50 acres of leased land. The transaction was officially completed on August 17, 2026.

Key Transaction Details

Financial and Regulatory Context

The company has confirmed the receipt of the total aggregate consideration of Rs 60 crore, which was paid in two tranches in accordance with the terms of the Memorandum of Understanding (MoU) signed on April 24, 2026.

Mastek Ltd has explicitly stated that the buyer, Caresoft Mobility Private Limited, does not belong to the promoter or promoter group companies. Furthermore, the company clarified that the transaction does not constitute a related-party transaction and is not part of any scheme of arrangement. The sale was deemed not to attract the terms of regulation 37A of the LODR Regulations, as it does not constitute an undertaking or substantially the whole of the company's undertaking under section 180 (1)(a) of the Companies Act, 2013.

Investor Takeaway

This divestment functions as an asset monetization exercise, converting a physical commercial asset into liquid capital. Shareholders should note that the transaction is finalized and the cash consideration has been received. There are no pending regulatory approvals or conditions precedent reported for this specific sale.

Publication Details

Mastek Ltd has filed a compliance announcement with the stock exchanges confirming the publication of its 44th Annual General Meeting (AGM) notice in select newspapers. The company confirms that the advertisements were published on August 17, 2026, in the following editions:

• The Financial Express: Ahmedabad edition (Gujarati Language)
• The Financial Express: Mumbai edition (English Language)
• Mumbai Lakshadweep: Mumbai edition (Marathi Language)

Meeting Overview

The 44th AGM is convened to be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in accordance with relevant regulatory guidelines.

Shareholder Information

The published notices cover key procedural details for shareholders, including:

• Remote E-Voting: Instructions and timelines for casting votes electronically.
• Final Dividend: Information regarding the proposed payment of the final dividend.

What Shareholders Should Know

Shareholders are advised that the full text of the notice and the newspaper clippings are available for review on the company's official website at www.mastek.com. Investors should monitor the company's investor relations portal for further updates regarding meeting access and instructions.

Key Highlights

Mastek Ltd has formally scheduled its 44th Annual General Meeting (AGM) to be conducted through electronic means. The company is actively ensuring that shareholders who have not registered their email addresses receive the necessary communications regarding the Annual Report for the financial year 2025-26.

Meeting Details

The 44th AGM will be held on Monday, September 07, 2026, at 5:00 P.M. (IST). In compliance with current regulatory guidelines, the meeting will take place through Video Conferencing (VC) or Other Audio Visual Means (OAVM).

Accessing the Annual Report

Shareholders can access the electronic copy of the Annual Report for FY 2025-26 and the AGM notice through the following channels:

• Company Website: Available at www.mastek.com.
• Stock Exchange Websites: Available on the BSE and NSE portals.
• Direct Path: Investors can navigate to the 'Annual Report 2025-26' section on the company's investor webpage.

Shareholder Guidance

To ensure receipt of future documents, the company has advised shareholders to update their email addresses based on their mode of holding:

• Electronic Mode: Update details directly through Depository Participants (DPs).
• Physical Mode: Register the email address by sending a request to investor_grievances@mastek.com or einward.ris@kfintech.com with the subject line 'Email Id Registration'.

Publication Details

Mastek Limited issued a notice on August 13, 2026, confirming the intimation of its 44th Annual General Meeting (AGM) and the record date for the payment of the final dividend. The advertisement was published in The Financial Express (Ahmedabad and Mumbai editions) and Mumbai Lakshadweep (Mumbai edition).

Purpose

The publication serves as a formal intimation to shareholders that the 44th AGM will be held through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in compliance with the Companies Act, 2013, and applicable SEBI regulations. It also notifies stakeholders of the record date for the final dividend payment.

Shareholder Instructions

• Documentation: The notice and annual report for the fiscal year 2025-26 have been dispatched via email to all members whose email addresses are registered with the company or their respective depository participants.
• Updates: Shareholders are requested to ensure their email addresses and bank mandate details are current with the company, registrar, or depository participants to facilitate dividend payments and receive meeting credentials.
• Access: The notice and advertisement are available on the company's official website at www.mastek.com.

Regulatory Context

The notice is issued in accordance with the Listing Obligations and Disclosure Requirements (LODR) regulations, adhering to circulars issued by the Ministry of Corporate Affairs (MCA) and SEBI regarding the conduct of shareholder meetings through electronic means.

Key Highlights

Corporate Action Details

The company has finalized the schedule for its 44th Annual General Meeting (AGM) and the record date for the final dividend payment. The AGM is scheduled for Monday, September 7, 2026, at 5:00 P.M. IST and will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), adhering to regulatory guidelines.

To determine the eligibility of shareholders for the final dividend of ₹16 per equity share, the company has set August 31, 2026, as the record date.

Dividend Timeline

The final dividend of ₹16 per equity share (face value ₹5) was originally recommended by the Board of Directors during their meeting on April 17, 2026. The payment of this dividend is subject to approval by the members at the upcoming AGM. Once approved, the dividend will be disbursed within 30 days from the date of approval.

Investor Takeaway

For existing shareholders, the key takeaway is the confirmation of the record date (August 31, 2026) and the AGM date (September 7, 2026). Investors should mark these dates to ensure they meet the eligibility requirements for the final dividend. The process follows standard regulatory compliance, and no new unexpected financial or operational updates were presented in this filing.

Corporate Governance and Dividend Update

Mastek Limited has provided the official schedule for its 44th Annual General Meeting (AGM) and confirmed the record date for the payment of its final dividend for the financial year 2025-26.

Key Event Details

Dividend Information

The Board of Directors has recommended a final dividend of ₹16 per equity share. The face value of each share is ₹5. The payment of this dividend is subject to approval by the members at the upcoming Annual General Meeting. If approved, the dividend will be paid within 30 days of the approval date.

Investor Takeaway

This announcement confirms the timeline for the company's annual shareholder meeting and the dividend payout process. Shareholders looking to be eligible for the final dividend must ensure they hold the shares before the record date of August 31, 2026. The meeting will be held virtually, consistent with regulatory guidelines for corporate governance meetings. Investors should mark these dates to manage their dividend expectations and participate in the AGM if desired.

Investor Engagement Details

Mastek Limited has scheduled an interaction with the following institutional investor:

Compliance and Disclosure

The company has confirmed that the discussions during this meeting will be based on industry and company-specific information that is already in the public domain. Mastek Limited explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be shared during this interaction, in adherence to regulatory protocols.

Event Participation

Mastek Limited has confirmed that its officials will participate in the upcoming 'Emkay Confluence 2026 – India: Full Throttle Ahead' investor conference. The interaction is scheduled for August 12, 2026, in Mumbai.

Investor Engagement

This event is part of the company's ongoing engagement with institutional investors and analysts. The discussion will focus on industry and company-specific developments that are already in the public domain.

Regulatory Compliance

The company has confirmed that no unpublished price-sensitive information (UPSI) will be shared during the meeting. This disclosure is provided in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, to ensure fair and transparent communication practices.

Strategic Partnership Overview

Mastek Inc., a wholly-owned step-down subsidiary of Mastek Limited, has entered into a strategic 'Platinum Partnership' with Innovaccer. The collaboration centers on implementing and scaling Innovaccer’s 'Gravity' Healthcare Intelligence Platform. This platform is designed to unify fragmented clinical, claims, and operational data into a single autonomous system, aiming to improve care outcomes and reduce costs for healthcare organizations.

Key Partnership Highlights

Strategic Importance

The partnership integrates Mastek’s engineering, data, and AI expertise—under its 'Lead with AI' approach—with Innovaccer's market-leading platform. Mastek aims to position itself as a leading AI transformation partner for the healthcare industry. For Innovaccer, the agreement provides access to Mastek’s extensive healthcare delivery expertise and its four decades of institutional relationships with health systems and governments across three continents.

Management Commentary

• Umang Nahata (CEO, Mastek): Noted that the partnership strengthens Mastek's ability to turn healthcare data into actionable intelligence, aligning with the firm's vision of becoming a leading AI transformation partner.
• Abhinav Shashank (Co-Founder and CEO, Innovaccer): Highlighted that Mastek’s decision to build delivery practices around the 'Gravity' platform validates the platform's ability to handle complex, high-stakes healthcare transformation programs.

What Looks Positive

• Strategic Positioning: Mastek is deepening its footprint in high-end healthcare digital transformation by leveraging specialized AI platforms.
• Market Access: The partnership facilitates expansion of the Gravity platform implementation across multiple key international markets, including North America, the UK, Europe, and the Middle East.
• Synergistic Leverage: The collaboration utilizes Mastek’s historical institutional relationships to drive adoption of Innovaccer’s technology.

What This Means for Investors

The announcement highlights Mastek's strategic pivot toward high-value, AI-integrated service delivery. By securing 'Platinum' status, Mastek is establishing a structured ecosystem partnership that could enhance its competitive differentiation in the healthcare sector. Investors should watch for the integration of this platform into Mastek’s existing healthcare service portfolio and monitor future updates regarding the scaling of these engagements.

Investor Takeaway

This partnership represents a calculated move by Mastek to strengthen its 'Lead with AI' strategy within a critical domain. The collaboration leverages existing institutional strengths to scale a recognized healthcare intelligence platform. For investors, the key monitoring point is the effective implementation and subsequent revenue contribution from these new AI-driven healthcare projects.

Key Highlights

Financial Snapshot

Mastek Ltd. reported a sequential revenue growth of 5% in INR terms and 1.2% in USD ($104.8 million). While the company maintained an operating EBITDA margin of 15.4%, performance was impacted by bench costs and collection delays, particularly in the Middle East due to geopolitical issues. Profit After Tax (PAT) stood at ₹105.9 crore.

Segment Performance

• North America: Grew 2% sequentially (constant currency) and 6% in INR, highlighted by a significant $25 million AI transformation deal in Salesforce Agent force.
• U.K.: Grew 3% sequentially (constant currency), maintaining a healthy EBIT of approximately 20%.
• Middle East: Experienced severe headwinds due to regional instability, leading to increased bench costs and delayed project ramp-ups.

AI Transformation Strategy

The company is aggressively positioning itself as an AI transformation provider. Mastek has initiated a "Customer Zero" internal strategy, replacing legacy systems with AI-native solutions. The company also appointed Amit Gajwani as the new Chief Operating Officer to drive delivery and talent transformation.

Risks and Watch Points

• Geopolitical Risk: Instability in the Middle East remains a primary headwind, affecting margins through bench costs.
• Pricing Pressure: Management acknowledged aggressive pricing competition, with discounts ranging between 15% and 25% in various deals.
• Tax Assessment: The company has filed an appeal with the Commissioner of Income Tax Appeals regarding an FY23 tax assessment, which carries a potential financial impact of ₹31 crore.
• Cost Factors: ESOP grants are expected to impact margins starting in Q2, with an estimated quarterly cost of $400,000 to $500,000.

Management Q&A Highlights

Investor Takeaway

Mastek's Q1 performance reflects a business managing a strategic shift toward AI transformation while navigating regional challenges. The strong order book growth, particularly the $25 million North American AI deal, suggests underlying demand. However, investors should closely monitor the Middle East situation for margin stabilization and track the impact of the upcoming ESOP costs and tax appeal resolution on overall profitability.

Announcement Context

Mastek Limited has formally complied with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by publishing the extract of its unaudited financial results for the quarter ended June 30, 2026, in newspapers.

Publication Details

The advertisements were published on July 23, 2026, across three distinct editions to ensure public dissemination of financial information:

• The Financial Express (Mumbai edition, English)
• The Financial Express (Ahmedabad edition, Gujarati)
• Mumbai Lakshadweep (Mumbai edition, Marathi)

These clippings are also available for public viewing on the company's official website.

Investor Takeaway

This filing confirms the company's adherence to standard regulatory transparency requirements regarding the publication of quarterly financial performance. No new operational or financial data is provided in this specific filing; it serves purely as a procedural update for public record. Investors are advised to rely on the formal results filed with the stock exchanges or hosted on the company's website for their financial analysis.

Earnings Call Update

Mastek Limited has made available the audio recording for the earnings conference call conducted on July 22, 2026. The call covered the company's unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Access to Recording

Investors can access the audio recording via the company's official website:

https://www.mastek.com/wp-content/uploads/2026/07/Analyst-Call-Q1FY27.mp3

Regulatory Filing

This disclosure was filed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, ensuring public access to the discussions held with investors and analysts.

What This Means for Investors

This update serves as a repository for those interested in reviewing the management commentary and Q&A session from the latest quarterly call. It does not contain fresh financial results or new corporate developments, but it remains a key resource for understanding the company's recent operational and financial narrative as presented by the leadership team.

Key Highlights

Financial Snapshot

Revenue and Income Analysis

Revenue from operations for the quarter stood at Rs 985.3 crore, demonstrating consistent top-line growth. The company reported a 5.0% sequential growth and a 7.7% growth compared to the same quarter last year, supported by momentum in financial services and the public sector.

Profitability Analysis

Net profit for Q1FY27 was Rs 105.9 crore, slightly lower by 0.3% sequentially compared to Rs 106.2 crore in Q4FY26, but 15.0% higher compared to Q1FY26. The EPS (Diluted) for the quarter was Rs 33.9.

Margin Analysis

The Operating EBITDA margin saw a sequential decline of 71 basis points, which management attributed to delayed collections in the Middle East region.

Balance Sheet and Debt Position

Total cash and investment position stood at Rs 945.4 crore at the end of the quarter. The company noted that this position improved over the last two quarters, indicating a strong liquidity profile despite various cash outflows.

Order Win and Business Update

The company continues to emphasize its 'Lead with AI' strategy, having secured 40+ new AI-related deals in Q1FY27. These AI deals now represent approximately 45% of the new order book. Major wins during the quarter include digital transformation projects for a UK council, modernization for a UK education technology group, and AI-led transformations for US federal and pharmaceutical entities.

Concerns and Watch Points

Number Relationship Analysis

The revenue grew by 5.0% QoQ to Rs 985.3 crore, and the order backlog grew 25.0% year-on-year to Rs 2,935.2 crore, signaling strong demand. However, this growth is currently facing efficiency headwinds, as evidenced by the 71 bps sequential margin contraction, largely tied to specific regional operational delays rather than a broad-based decline in performance.

What This Means for Investors

Mastek's core business continues to show resilience with consistent top-line growth and a robust order book driven by AI-led demand. While the margin dip due to collection issues in the Middle East is a point of note, the company's strong cash position and strategic focus on AI transformation provide a foundation for long-term growth. Investors should watch for improvements in collection cycles in the coming quarters.

Investor Takeaway

The Q1FY27 results show a company in transition toward an AI-led model, with solid order booking and revenue growth. The primary challenge remains the margin impact from regional collection delays. Existing shareholders should track the company's ability to resolve these collection timelines and maintain its AI momentum in the coming quarters.

Key Highlights

Financial Snapshot

Revenue and Income Analysis

Revenue from operations for Q1FY27 stood at ₹985.3 crore, representing a 5.0% growth sequentially and 7.7% growth on a year-on-year basis. Total income for the quarter was ₹997.3 crore.

Profitability and Margin Analysis

The operating EBITDA margin was 15.4% for the quarter, compared to 16.1% in the previous quarter (Q4FY26). This reflects a sequential decline of 71 basis points, which management has attributed to delayed collections in the Middle East region due to geopolitical uncertainties. Net profit remained relatively flat sequentially at ₹105.9 crore, compared to ₹106.2 crore in the prior quarter.

Order Book and Operations

The 12-month order backlog reached ₹2,935.2 crore, reflecting 25.0% year-on-year growth in rupee terms. The company reported 40+ new deals in the quarter, with management noting that approximately 45% of the new order book is derived from AI-related engagements. The company also maintained a strong liquidity position, with cash and cash equivalents (including mutual funds) at ₹945.4 crore.

Concerns and Watch Points

What This Means for Investors

For investors, Mastek demonstrates a resilient revenue growth profile and strong demand for its AI-led services, as evidenced by a growing order backlog. However, the margin compression caused by geopolitical issues in the Middle East serves as a necessary watch point. The company's focus on maintaining a healthy cash position provides some cushion as they navigate these operational headwinds.

Investor Takeaway

Mastek's Q1FY27 performance shows a company successfully executing its 'Lead with AI' strategy, with strong top-line growth and order intake. The core focus for the coming quarters will be the firm's ability to navigate geopolitical uncertainties in the Middle East to normalize collection cycles and improve operating margins. Existing shareholders should track the consistency of AI-led deal conversion and the stabilization of margin metrics in upcoming reports.

Financial Performance

Mastek Limited has released its financial results for the first quarter of the financial year 2026. The consolidated results show a steady performance in revenue and profitability for the period ending June 30, 2026.

Financial Snapshot (Consolidated)

Financial Snapshot (Standalone)

Segment Performance

The UK & Europe operations continue to serve as the dominant revenue segment for the group, contributing over two-thirds of the total consolidated revenue for the quarter.

Corporate Governance and Action

• Governance Update: The Board of Directors approved amendments to the "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information." This adjustment is part of the company's compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
• ESOP Allotment: The company’s paid-up equity share capital increased by ₹0.17 lakh (3,442 equity shares) due to the exercise of employee stock options under Plan VI and Plan VII.
• Auditor Review: The consolidated and standalone financial results for the quarter were subject to a limited review by the statutory auditors, Walker Chandiok & Co LLP, who issued an unmodified report.

Investor Takeaway

For investors, this update provides a standard view of Mastek Limited’s operational performance for the first quarter. The company maintains a consistent geographic revenue mix, with a heavy concentration in the UK & Europe market. The governance changes regarding the Fair Disclosure Code reflect ongoing compliance with regulatory standards. Investors may monitor the segment-wise contribution and consolidated profitability trends in upcoming quarters to gauge business momentum.

Key Highlights

Financial Snapshot

Revenue and Income Analysis

Consolidated revenue from operations for the quarter ended June 30, 2026, was ₹985.25 crore (₹98,525 lakh), showing growth over the ₹914.70 crore (₹91,470 lakh) reported in the same quarter last year. Standalone revenue for the quarter was ₹244.60 crore (₹24,460 lakh).

Profitability Analysis

Consolidated net profit for the quarter stood at ₹105.88 crore (₹10,588 lakh), higher than the ₹92.05 crore (₹9,205 lakh) reported in the June 2025 quarter. The Basic EPS improved to ₹34.16 from ₹29.75 in the same period last year. Standalone net profit for the quarter ended June 30, 2026, was ₹57.16 crore (₹5,716 lakh).

Corporate Action Details

The paid-up equity share capital of the company increased by ₹0.0017 crore (₹0.17 lakh) during the quarter. This represents the allotment of 3,442 equity shares of ₹5 each, resulting from the exercise of options by employees under the company's ESOP schemes (Plan VI and Plan VII).

Board Decision or Meeting Update

The Board of Directors meeting held on July 21, 2026, approved amendments to the 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information'. This update is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.

What This Means for Investors

The company continues to report steady growth in both top-line revenue and bottom-line profit on a year-on-year basis. Investors should note the incremental impact of regulatory compliance updates, such as the Labour Codes mentioned in previous periods, which remain a point of ongoing monitoring. The governance update regarding price-sensitive information is a routine compliance measure.

Investor Takeaway

Mastek’s latest results reflect consistent performance. Investors should track geographical revenue trends across the UK & Europe, North America, and AMEA segments, as these remain key drivers. The minor capital increase due to ESOP exercises indicates ongoing employee incentive participation, which is standard. Overall, the company is following its regular financial reporting and compliance cycle.

Key Highlights

Corporate Action Details

HDFC Mutual Fund has disclosed an acquisition of 86,746 equity shares of Mastek Ltd via the open market. This purchase brings their aggregate holding to 15,68,910 shares, effectively taking their total equity stake to 5.06%. The transaction occurred on July 15, 2026. This disclosure is mandatory under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which is triggered when an investor's shareholding crosses the 5% threshold of a company's paid-up share capital.

Ownership Structure Update

Following the acquisition, the shareholding profile of Mastek Ltd has shifted, with HDFC Mutual Fund now holding more than 5% of the total paid-up share capital. This change highlights ongoing interest from institutional investors in the company.

What This Means for Investors

Investors often monitor significant changes in shareholding by large institutional investors like mutual funds. A move by HDFC Mutual Fund to increase its stake to 5.06% reflects an uptick in institutional exposure to the company. While this is a standard regulatory filing, it serves to keep the market informed about the changing composition of the company's major shareholders.

Investor Takeaway

Mastek Ltd has confirmed a regulatory disclosure regarding an increase in HDFC Mutual Fund's shareholding. By acquiring 86,746 additional shares, HDFC Mutual Fund has moved its stake from 4.78% to 5.06%. This event is a routine regulatory filing under SEBI's SAST regulations. Shareholders should view this as a change in the company's institutional ownership structure.

Institutional Shareholding Update

Mastek Ltd has received a disclosure indicating that HDFC Mutual Fund (via HDFC Small Cap Fund) has increased its stake in the company. This acquisition of shares occurred on July 15, 2026, through open market transactions. Following this purchase, the total shareholding of the fund has crossed the 5% regulatory threshold, necessitating a disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Acquisition Details

Company Capital Structure

The total paid-up equity share capital of Mastek Ltd as of the disclosure date is ₹15.50 crore, consisting of 3,10,00,782 equity shares with a face value of ₹5 each.

What This Means for Investors

The crossing of the 5% equity threshold by a mutual fund is a standard but important event for shareholders to monitor. It indicates that the investor has become a "substantial shareholder" under regulatory definitions, which can sometimes influence shareholding patterns and liquidity. The acquisition was executed via open market transactions, which suggests the investor was purchasing shares at prevailing market prices rather than through a preferential allotment or strategic deal. Investors should note this as a sign of institutional engagement with the stock.

Investor Takeaway

This disclosure provides transparency regarding changing ownership patterns in Mastek Ltd. While the accumulation by HDFC Mutual Fund signals institutional confidence or portfolio adjustment, it does not directly alter the company's business operations or financial results. Existing shareholders should view this as a change in the investor base rather than an immediate catalyst for business performance. Future filings should be monitored to see if this institutional interest continues or if there are further changes in the shareholding structure.

Key Highlights The Stakeholder's Relationship Committee of Mastek Limited approved the allotment of 1,625 equity shares under its Employee Stock Option (ESOP) plans. These shares were issued to eligible employees who exercised their vested options under Plan VI and Plan VII. The newly allotted shares rank pari-passu with the company's existing equity shares. ## Important Figures Used | Metric / Item | Context | Value |

| --- | --- | --- |
| Shares Allotted | ESOP Allotment | 1,625 shares |
| Post-Allotment Capital | Total Issued Shares | 3,10,02,407 shares |
| Post-Allotment Capital Value | Total Value | ₹15.50 crore (₹1,550.12 lakh) | ## Corporate Action Details The allotment is a standard compliance exercise under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The shares were issued at varying exercise prices, specifically at face value (Rs 5) and at a premium (Rs 188), reflecting the terms of the specific ESOP grants. There is no lock-in period for these shares. ## What This Means for Investors For existing shareholders, this update is a routine notification of capital increase resulting from employee stock compensation. The scale of the allotment is very small relative to the total share capital, resulting in minimal dilution. It primarily signals the execution of established employee retention strategies. ## Investor Takeaway This announcement is a minor administrative update confirming the issuance of equity under existing employee incentive plans. There is no material financial or operational impact on the company. Investors should note this as a standard corporate compliance disclosure.

Key Highlights

Earnings Call Details

The company has scheduled an earnings conference call to discuss the financial results for the quarter ended June 30, 2026. Management representation will include Mr. Umang Nahata (Chief Executive Officer, Mastek Group) and Mr. Deepak Kedia (Chief Financial Officer, Mastek Group). This session provides an opportunity for investors and analysts to engage with the leadership team regarding the company's business outlook.

Corporate Compliance

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for the company's shares was closed starting June 30, 2026. This restriction remains in effect until 48 hours after the financial results are made public. The window is scheduled to re-open on July 24, 2026.

Operational Snapshot

Mastek continues to operate as a global provider of enterprise AI, digital, and cloud services. The company maintains a presence in over 40 countries, supported by a workforce of nearly 5,000 employees and approximately 400 active customers. The firm serves key sectors including Public Sector, Healthcare, Retail, Manufacturing, Higher Education, and Financial Services.

Summary

• Mastek Limited has scheduled one-to-one meetings with analysts and institutional investors on May 4, 2026.
• The meetings will be with I-Wealth Management LLP and ASK Investment Managers Limited.
• Discussions will focus on industry and company-specific developments already in the public domain.
• The company confirmed that no unpublished price-sensitive information (UPSI) will be shared during these meetings.

Key Numbers & Dates

• Date: May 4, 2026
  • Event: Analyst/Institutional Investor Meetings
  • Participants: I-Wealth Management LLP, ASK Investment Managers Limited

Summary

• Mastek Limited has signed a Memorandum of Understanding (MOU) for the sale of its commercial building in Chennai.
• The aggregate sale consideration is ₹60 crore, which will be received in two tranches.
• The buyer of the property is Caresoft Mobility Private Limited.
• The transaction is subject to the execution of definitive agreements and obtaining necessary regulatory and statutory approvals.

Key Numbers & Dates

• Aggregate consideration: ₹60.00 cr
• MOU executed date: 2026-04-24
• Built-up area of building: 1,57,233 Sq. Ft.
• Leased land area: 15.50 acres

What Changes for the Business

• Mastek Limited is divesting its commercial building located at Mahindra World City, SEZ, Chengalpattu, Chennai.
• The sale involves a property with approximately 1,57,233 Sq. Ft. built-up area on 15.50 acres of leased land.

⚠️ What Could Go Wrong (source-based)

• [Deal] The transaction is subject to the execution of definitive agreements.
• [Deal] The transaction is subject to receipt of necessary approvals, including from relevant regulatory and statutory authorities.

What to Track Next

• Execution of definitive sale agreements.
• Receipt of all required regulatory and statutory approvals for the sale to be completed.

🧾 Concall Snapshot

• Company: Mastek Limited
• Period: Q4 FY '26
• Date: April 20, 2026
• Who spoke: Umang Nahata (CEO), Deepak Kedia (CFO)

🗣️ Prepared Remarks Highlights

• Stable Performance: Management delivered 3.6% QoQ revenue growth in INR despite macro headwinds.
• Order Backlog: 12-month backlog reached $300.4 million, up 13.5% YoY in dollar terms.
• Geographic Resets: North America underwent a leadership and team reset; UK business grew 11% in pound terms.
• AI Progress: Added 27+ AI-focused customer programs; internal operations saw a 12% increase in revenue per resource due to AI efficiency gains.
• Sector Highlights: Financial Services was cited as the 'star of the quarter', while Healthcare saw a temporary timing gap dip.

🎯 Guidance & Outlook

• FY27 Growth: Expected to grow faster than FY26.
• Margins: Targeted to remain stable between 16% and 16.1%.
• Taxation: Effective tax rate projected at 24.5% to 24.7% for future quarters.
• Model Shift: Transitioning from Time & Material (T&M) to more outcome-focused and fixed-bid contracts.

❓ Investor/Analyst Q&A Highlights

• Revenue vs. Order Book: Ankur Kumar questioned the gap between 3% YoY revenue growth and a strong order book. CEO Umang Nahata noted that order book ramp-ups have started and will reflect soon.
• AI Deal Scalability: Amit Chandra asked about small AI deal sizes (~$1M). Management explained these are early 'discovery' stages that set the foundation for larger enterprise-scale AI business.
• Renewal Pricing: Amit Chandra inquired about discounts. Management confirmed renewal environments are 'extremely price competitive,' citing 10-15% discounts as standard.
• M&A Strategy: Varun Kulkarni asked about using cash for acquisitions. Management is actively looking at domain-specific assets rather than just technical skill sets.

⚠️ Risks & Red Flags

• Pricing Pressure: Explicitly mentioned 'severe pricing competitiveness' and AI-led pressure on renewals.
• Geopolitical Risks: Turbulence in the Middle East is creating 'short-term headwinds'.
• Labor Code Impact: INR 30 crores catch-up impact on PAT due to Labor Code changes.
• Uncertainty: Management stated they are entering a market with 'a little more uncertainty than before'.

🧠 Retail Investor Takeaway

Mastek is navigating a transition year ('year of resets') with a focus on stabilizing North America and shifting toward AI-vertical services. While the 12-month backlog of $300.4 million suggests growth visibility, retail investors should monitor the impact of aggressive pricing discounts (10-15%) on margins and the ongoing geopolitical risks in the Middle East.

Summary

• Mastek Limited has shared a link to the audio recording of its earnings conference call for the financial year ended March 31, 2026.
• The call covered the Audited (Standalone and Consolidated) Financial Results of the Company for the year.

Key Numbers & Dates

• Document Date: April 20, 2026
• Financial Year Covered: Year ended March 31, 2026

Odyssey Corporation Limited has issued a notice for a postal ballot, informing shareholders about resolutions to be voted upon. These include the regularization of Additional Directors Mr. Wilson Marshal John and Mr. Hemanshu Ramniklal Mehta, adoption of new Memorandum and Articles of Association, approval of related party transactions, and authorization for loan advancements. The company has completed dispatch of the notice and commenced e-voting. The report also includes financial results from Mastek Limited, Waaree Renewable Technologies Limited, and Sanathnagar Enterprises Limited, as well as updates from J. Kumar Infraprojects Limited.

National Standard (India) Limited has officially released its audited financial results for the quarter and full financial year concluded on March 31, 2026. The company published this announcement through advertisements in the Financial Express and Mumbai Lakshadeep, adhering to SEBI's disclosure requirements. These financial statements are also accessible on the company's official website, www.nsil.net.in. Additionally, other listed entities including Mastek Limited, Waaree Renewable Technologies Limited, and J. Kumar Infraprojects Limited have also disclosed their audited financial results for the same period, presenting key figures such as revenue and net profit.

Summary

• Mastek's Board of Directors met on April 17, 2026, to approve the audited financial results for the fiscal year ended March 31, 2026.
• The auditors, M/s. Walker Chandiok & Co LLP, have issued an unmodified opinion on the company's consolidated and standalone financial statements.
• The Board recommended a final dividend of 320% (Rs. 16 per share) for FY26, subject to shareholder approval.

Key Numbers & Dates

• Board Meeting Date: April 17, 2026
• Financial Year End: March 31, 2026
• Recommended Final Dividend (FY26): Rs. 16 per share (320%)
• Total Dividend for FY26: Rs. 24 per share (480%)
• Total Dividend for FY25: Rs. 23 per share (460%)
• Consolidated Revenue (FY26): ₹3,69,875 lakhs
• Consolidated Net Profit (FY26): ₹40,400 lakhs

What Changes for the Business

• The company has officially announced its audited financial performance for the fiscal year 2025-26.
• A final dividend recommendation has been made, pending shareholder approval, which will impact shareholder returns.

Results Snapshot

Consolidated Financials for the year ended March 31, 2026:

• Revenue from operations: ₹3,69,875 lakhs
• Profit after tax: ₹40,400 lakhs

📊 Performance Summary

• Reporting Period(s): Quarterly (ended March 31, 2026) and Annual (year ended March 31, 2026).
• Unit: Rs. In lakhs

(A) Quarterly Results

• Standalone: Total Income of 25,025 lakhs (₹250.25 cr) and Net Profit of 5,716 lakhs (₹57.16 cr).
• Consolidated: Total Income of 96,187 lakhs (₹961.87 cr) and Net Profit of 10,615 lakhs (₹106.15 cr).
• YoY (Consolidated): Total Income grew 5.82% (96,187 vs 90,900 lakhs).
• YoY (Standalone): Total Income grew 4.29% (25,025 vs 23,995 lakhs).

(B) Annual Results

• Standalone: Total Income of 94,414 lakhs (₹944.14 cr) and Net Profit of 20,244 lakhs (₹202.44 cr).
• Consolidated: Total Income of 3,76,916 lakhs (₹3,769.16 cr) and Net Profit of 40,400 lakhs (₹404.00 cr).
• YoY (Consolidated): Total Income increased 8.39% (3,76,916 vs 3,47,751 lakhs). Net Profit grew 7.47% (40,400 vs 37,593 lakhs).
• YoY (Standalone): Total Income slightly decreased by 1.64% (94,414 vs 95,990 lakhs). Net Profit significantly increased 44.25% (20,244 vs 14,034 lakhs).

✅ What Looks Positive

• Growth: Consolidated annual revenue grew by 8.39%.
• Profitability: Consolidated annual net profit increased by 7.47% YoY.
• Dividend: High total dividend payout of ₹24 per share (480%) for the financial year.
• Auditor Opinion: Statutory auditors issued an unmodified opinion, confirming the statements give a true and fair view.
• Standalone Profit Spike: Standalone net profit rose by 44.25% despite nearly flat revenue.

⚠️ Risk Alerts & Concerns

• Exceptional Losses: The company recorded exceptional item losses of 3,375 lakhs standalone and 3,012 lakhs consolidated for the full year.
• Standalone Revenue Decline: On a restated basis, standalone annual Total Income showed a 1.64% decline.
• Labour Code Impact: Incremental impact of new labor codes totaled 2,135 lakhs (gratuity) and 877 lakhs (compensated absences) which may affect future margins.

🧠 Investor Takeaway

Mastek Limited has delivered a stable consolidated performance with roughly 8% growth in both revenue and profit. The standout feature is the significant standalone profit increase, though this was partly influenced by the restatement following the amalgamation of a subsidiary. The healthy dividend of ₹24 suggests strong cash generation, and the clean auditor opinion provides transparency on the restated figures.

📊 Performance Summary

• Reporting Period(s): Quarter and Year ended March 31, 2026
• Unit: Rs. in lakhs

(A) Quarterly Results

• Standalone: Total Income of 25,025 lakhs (₹250.25 Cr) and Net Profit of 5,716 lakhs (₹57.16 Cr).
• Consolidated: Total Income of 96,187 lakhs (₹961.87 Cr) and Net Profit of 10,615 lakhs (₹106.15 Cr).
• YoY Comparison (Consolidated): Total Revenue grew to 96,187 lakhs from 90,900 lakhs, an increase of 5.82%.
• YoY Comparison (Standalone): Total Revenue grew to 25,025 lakhs from a restated 23,995 lakhs, an increase of 4.29%.

(B) Annual Results

• Standalone: Total Income of 94,414 lakhs (₹944.14 Cr) and Net Profit of 20,244 lakhs (₹202.44 Cr).
• Consolidated: Total Income of 3,76,916 lakhs (₹3,769.16 Cr) and Net Profit of 40,400 lakhs (₹404.00 Cr).
• YoY Comparison (Consolidated): Total Revenue increased from 3,47,751 lakhs to 3,76,916 lakhs, a growth of 8.39%.
• YoY Comparison (Standalone): Total Revenue decreased from a restated 95,990 lakhs to 94,414 lakhs, a decline of 1.64%.

✅ What Looks Positive

• Consolidated annual total income grew by 8.39% year-over-year.
• Consolidated net profit for the year increased from 37,593 lakhs to 40,400 lakhs.
• The Board has recommended a significant final dividend of 320% (₹16 per share), bringing the total dividend for the year to ₹24 per share.
• Auditors provided an unmodified opinion, meaning they found the financial reports to be reliable and fair.

⚠️ Risk Alerts & Concerns

• On a standalone basis, annual total income showed a slight decline of 1.64% compared to the restated figures of the previous year.
• The company reported exceptional item losses in both standalone (₹3,375 lakhs) and consolidated (₹3,012 lakhs) annual results.
• Standalone figures required restatement due to an amalgamation, which complicates direct historical comparisons without careful review of notes.

🧠 Investor Takeaway

Mastek Limited has demonstrated stable growth on a consolidated level, driven by an 8.39% increase in annual revenue and improved net profits. While standalone revenue experienced a marginal annual dip, the quarterly performance shows recovery. The healthy dividend payout and clean audit report are positive indicators of management's confidence and financial transparency.

Summary

• Mastek reported revenue of ₹938.0 crore for Q4FY26, a 3.6% year-on-year increase.
• The company's 12-month order backlog grew by 24.4% YoY to ₹2,849.2 crore.
• A final dividend of ₹16 per share was proposed, aggregating to 480% for FY26.
• The company highlighted its AI-first strategy and secured several new deals across various sectors.

Key Numbers & Dates

• Q4FY26 Revenue from Operations: ₹938.0 crore (up 3.6% YoY)
• FY26 Revenue from Operations: ₹3,698.8 crore (up 7.0% YoY)
• Q4FY26 Net Profit: ₹106.2 crore (up 30.9% YoY)
• FY26 Net Profit: ₹404.0 crore (up 7.5% YoY)
• 12 Months Order Backlog (as of March 31, 2026): ₹2,849.2 crore (up 24.4% YoY)
• Proposed Final Dividend: ₹16 per share
• Total Dividend for FY26: 480%
• Financial Year End: March 31, 2026
• Results Announcement Date: April 17, 2026

What Changes for the Business

• The company continues to focus on its 'Lead with AI' strategy, integrating AI across solutions and operations to drive transformation.
• New leadership appointments (Chief Financial Officer and Chief Human Resources Officer) have been made to support future growth.
• Mastek secured significant new deals in healthcare, public sector, financial services, and retail, indicating diversification and strategic wins.

⚠️ What Could Go Wrong (source-based)

• The report mentions "macroeconomic environment remains uncertain" but states the company is well-positioned due to client relationships, deal pipeline, and operational rigor.

Results Snapshot

Consolidated Financial Highlights Q4FY26:

• Revenue from Operations: ₹938.0 crore (3.6% YoY growth)
• Total Income: ₹961.9 crore (5.8% YoY growth)
• Operating EBITDA: ₹150.7 crore (8.6% YoY growth)
• PAT: ₹106.2 crore (30.9% YoY growth)
• PAT Margin: 11.0%

Consolidated Financial Summary FY26:

• Revenue from Operations: ₹3,698.8 crore (7.0% YoY growth)
• Total Income: ₹3,769.2 crore (8.4% YoY growth)
• Operating EBITDA: ₹585.6 crore (7.2% YoY growth)
• PAT: ₹404.0 crore (7.5% YoY growth)
• PAT Margin: 10.7%

What to Track Next

• Continued execution of the 'Lead with AI' strategy and its impact on revenue and profitability.
• Performance in key geographies like the UK and North America, with specific mention of positive indicators in North America.
• Progress on integrating new leadership appointments and their contribution to business growth.
• Further details on the pipeline quality and deal closures in emerging growth areas.

Summary

• Mastek reported Q4FY26 revenue of ₹938.0 crore, a 3.6% year-on-year increase.
• Full-year FY26 revenue grew 7.0% to ₹3,698.8 crore.
• The company proposed a final dividend of ₹16 per share, amounting to 480% for FY26.
• The 12-month order backlog reached ₹2,849.2 crore, up 24.4% YoY.

Key Numbers & Dates

• Q4FY26 Revenue: ₹938.0 crore (3.6% YoY growth)
• FY26 Revenue: ₹3,698.8 crore (7.0% YoY growth)
• FY26 Operating EBITDA: ₹585.6 crore (7.2% YoY growth)
• FY26 Net Profit: ₹404.0 crore (7.5% YoY growth)
• 12 Months Order Backlog (as of March 31, 2026): ₹2,849.2 crore (24.4% YoY growth)
• Proposed Final Dividend: ₹16 per share (cumulating to 480% for FY26)
• Results Announcement Date: April 17, 2026
• Financial Year End: March 31, 2026

What Changes for the Business

• Mastek is advancing its 'Lead with AI' strategy, aiming for measurable outcomes and strengthened capabilities.
• The company has strengthened its leadership with the appointment of a new Chief Financial Officer and Chief Human Resources Officer.

⚠️ What Could Go Wrong (source-based)

• [Other] The company operates in an environment with potential risks including competition, growth dynamics, pricing environment, recruitment and retention challenges, wage inflation, and evolving law and regulatory policies.

Results Snapshot

Consolidated Financial Highlights Q4FY26:

• Revenue from Operations: ₹938.0 crore (3.6% YoY growth)
• Operating EBITDA: ₹150.7 crore (8.6% YoY growth)
• PAT: ₹106.2 crore (30.9% YoY growth)

Consolidated Financial Summary - FY26:

• Revenue from Operations: ₹3,698.8 crore (7.0% YoY growth)
• Operating EBITDA: ₹585.6 crore (7.2% YoY growth)
• PAT: ₹404.0 crore (7.5% YoY growth)

What to Track Next

• No specific forward-looking statements or next steps were detailed in the provided text.

Summary

• Management representatives of Mastek Limited will participate in a Non-Deal Roadshow.
• The roadshow is scheduled for April 21, 2026, in Mumbai.
• Meetings will be with institutional investors and analysts to discuss public industry and company-specific developments.

Key Numbers & Dates

• Roadshow Date: April 21, 2026
• Venue/Mode: Mumbai / Physical
• Timing: 09:00 AM - 06:00 PM IST

⚠️ What Could Go Wrong (source-based)

• [Other]: The schedule of the meetings may change due to exigencies on the part of the investors or the company.

📊 Performance Summary

• Reporting Period(s): Financial Year ended March 31, 2026 (Board Meeting Notice).

Upcoming Key Dates

• Board Meeting: April 17, 2026, to consider audited financial results and a final dividend for the 2025-26 fiscal year.
• Earnings Call: April 20, 2026, at 10:00 AM IST.

✅ What Looks Positive

• The company's board is scheduled to consider recommending a final dividend for the financial year 2025-26.
• Mastek maintains an operational scale with close to 5,000 employees and 400+ active customers across more than 40 countries.

⚠️ Risk Alerts & Concerns

• No financial performance risks are identifiable from this administrative notice as the actual financial results for the period ended March 31, 2026, have not yet been released.

🧠 Investor Takeaway

This announcement is a formal notice of the upcoming release of full-year audited results. Investors should monitor the outcomes of the board meeting on April 17, 2026, for specific financial figures and the recommended dividend amount.

Summary

• Mastek Limited has submitted its compliance certificate for the quarter ended March 31, 2026, under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
• The certificate was issued by the company's Registrar and Share Transfer Agent, KFin Technologies Limited.
• The filing confirms that details of dematerialized/rematerialized securities were furnished to all stock exchanges where Mastek Limited is listed.

Key Numbers & Dates

• Quarter ended: March 31, 2026
• Certificate issued by KFin Technologies dated: April 1, 2026
• Mastek Limited letter dated: April 6, 2026

Entities Involved

• Company: Mastek Limited
• Registrar & Share Transfer Agent: KFin Technologies Limited
• Regulatory Filings submitted to: BSE Limited, The National Stock Exchange of India Limited, National Securities Depository Limited, Central Depository Services (India) Limited.

Summary

• Mastek Limited has approved the grant of 6,00,000 (Six Lakhs) stock options to eligible employees under ESOP Plan VI and VII.
• The options have an effective grant date of April 1, 2026, and an exercise price of Rs. 1,000 per option.
• Vesting is contingent on performance conditions and will occur in the 3rd, 4th, and 5th years post-grant.

Key Numbers & Dates

• Options Granted: 6,00,000 (Six Lakhs) options under ESOP Plan VI and VII.
• Grant Effective Date: April 1, 2026.
• Exercise Price: Rs. 1,000 per option.
• Vesting Schedule: Up to 100% vest at the end of the 3rd year, with subsequent vesting in the 4th and 5th years, subject to performance conditions.
• Exercise Period: Maximum of 7 years from the date of vesting.
• Face Value per Share: Rs. 5 (Rupees Five) each.

What Changes for the Business

• The grant of ESOPs is intended to incentivize and retain key employees by aligning their interests with the company's performance and growth.
• It may lead to future dilution of equity shares upon exercise of these options.

⚠️ What Could Go Wrong (source-based)

• [Execution] Vesting of options is subject to the fulfillment of pre-set performance conditions defined by the Nomination and Remuneration Committee. Failure to meet these conditions could lead to unvested options lapsing.

Summary

• Mastek Limited announced a virtual investor meeting with Fidelity International for March 31, 2026.
• The one-to-one interaction will focus on industry and company-specific developments already in the public domain.
• No unpublished price sensitive information (UPSI) will be shared during the meet.

Key Numbers & Dates

• Meeting Date: March 31, 2026
• Meeting Timing: 3:30 PM
• Report Date: March 30, 2026

⚠️ What Could Go Wrong (source-based)

• [Other] The schedule of the meeting may undergo changes due to exigencies on the part of the investor or company.

What to Track Next

• The company's website will host this information.
• Note any potential schedule changes.

Summary

• Mastek Limited will close its trading window starting March 31, 2026.
• This closure is in compliance with SEBI regulations for the declaration of financial results for the year ending March 31, 2026.
• The trading window will reopen 48 hours after the financial results are submitted to the stock exchanges.

Key Numbers & Dates

• Trading Window Opens: March 31, 2026
• Trading Window Closes: 48 hours after submission of Financial Results for the year ending March 31, 2026
• Financial Year End: March 31, 2026

What Changes for the Business

• Designated Persons and their immediate relatives are restricted from trading in the company's shares during the closure period to prevent insider trading.

What to Track Next

• The company will communicate the date of the proposed Board Meeting for the declaration of financial results in due course.

Summary

• Mastek Limited will hold one-to-one analyst and institutional investor meetings on March 19, 2026.
• Interactions will be with Anand Rathi Share and Stock Brokers Ltd. and ICICI Direct Ltd.
• Discussions will focus on industry and company-specific developments already in the public domain.
• The company confirmed that no unpublished price sensitive information (UPSI) will be shared.

Key Numbers & Dates

• Meeting Date: March 19, 2026

⚠️ What Could Go Wrong (source-based)

• [Execution] The schedule of the meetings may change due to exigencies from the investors' or company's side.

Summary

• Mastek Limited has scheduled Analyst and Institutional Investor Meets for March 18, 2026.
• The company will hold one-to-one meetings with Macquarie Capital Securities and Batlivala & Karani Securities.
• Discussions will focus on publicly available information; no UPSI will be shared.
• The meeting schedule is subject to change.

Key Numbers & Dates

• Analyst / Institutional Investor Meets: March 18, 2026
• First Meeting: Macquarie Capital Securities (India) Pvt. Ltd. at 11:00 AM
• Second Meeting: Batlivala & Karani Securities India Pvt. Ltd. at 12:30 PM
• Announcement Date: March 17, 2026

⚠️ What Could Go Wrong

• [Other] The schedule of meetings may undergo changes due to exigencies on the part of the investors or the Company.

Summary

• Mastek Limited's credit ratings for its bank facilities have been reaffirmed by ICRA Limited.
• Key ratings for fund-based and non-fund based limits have been maintained.
• The total value of bank facilities has seen a reduction.

Key Numbers & Dates

• Total Bank Facilities (Previous): ₹191.90 crore (rated by ICRA)
• Total Bank Facilities (Current): ₹106.00 crore (rated by ICRA)
• Long-term – Fund-based limits (Cash credit): ₹50.00 crore. Rating reaffirmed as [ICRA]AA- (Stable).
• Short-term – Non-fund based limits: ₹50.00 crore. Rating reaffirmed as [ICRA]A1+.
• Long-term/short-term – Fund based/non-fund based: ₹6.00 crore. Rating reaffirmed as [ICRA]AA- (Stable)/[ICRA]A1+.
• Long-term -Non-fund based facilities: Previous ₹85.90 crore. Current rating not specified in table.
• Announcement Date: March 6, 2026

What Changes for the Business

• The reaffirmation of ratings suggests continued financial stability as assessed by ICRA.
• The reduction in total bank facilities indicates a potential deleveraging or restructuring of borrowings.

What to Track Next

• Monitor ICRA's detailed rationale report for deeper insights into the rating reaffirmation and the reasons for the facility amount reduction.

Summary

• Mastek Limited has allotted 5,966 equity shares to eligible employees under its Employee Stock Option Plan (ESOP).
• This increases the total issued shares to 3,09,97,340.
• The paid-up share capital has risen to ₹15,49,86,700 (approximately ₹15.50 crore).
• The new shares rank pari-passu with existing shares.

Key Numbers & Dates

• Shares Allotted: 5,966 equity shares
• Face Value per Share: ₹5
• Previous Total Shares: 3,09,91,374
• Previous Paid-up Capital: ₹15,49,56,870 (₹15.50 cr)
• New Total Shares: 3,09,97,340
• New Paid-up Capital: ₹15,49,86,700 (₹15.50 cr)
• Allotment Date: March 05, 2026

What Changes for the Business

• The total number of outstanding equity shares has increased slightly.
• The company's paid-up share capital has seen a marginal increase.
• The new shares are identical to existing ones and carry the same rights.

What to Track Next

• None specified in the report.

Summary

• Mastek's UK subsidiary has secured a significant framework engineering contract worth approximately £85 million with the UK Home Office.
• The contract is for scaling the ATLAS platform, a core system for the UK's Migration & Borders Technology Portfolio.
• This engagement is expected to bolster Mastek's partnership with the UK public sector.

Key Numbers & Dates

• Contract Value: £85 million (circa)
• Contract Value: Approximately $110 million+
• Announcement Date: March 05, 2026

What Changes for the Business

• The service aims to make the ATLAS platform's common components more scalable, resilient, and highly available.
• Mastek anticipates significant growth from this contract over the coming years.
• The project will utilize high-end engineering techniques and AI-driven accelerators for casework and platform modernization.

⚠️ What Could Go Wrong

• No specific risks are mentioned in the provided text that can be extracted as per the guidelines.

Concall: Investor Questions & Management Answers

• Not applicable.

Results Snapshot

• Not applicable.

What to Track Next

• No specific next steps or tracking items are mentioned in the provided text.

Summary

• Mastek Limited will hold a virtual Analyst/Institutional Investor Meet on March 5, 2026.
• The meeting is a one-to-one interaction with HDFC AMC.
• Discussions will focus on industry and company-specific developments already in the public domain.
• No unpublished price sensitive information (UPSI) will be shared during the meet.

Key Numbers & Dates

• Analyst/Investor Meet Date: March 5, 2026
• Meeting Time: 03:30 PM
• Intimation Date: March 4, 2026

⚠️ What Could Go Wrong (source-based)

• [Other] The schedule of the investor meet may undergo change due to exigencies on the part of the investor or Company.

Summary

• Mastek Limited has scheduled an Analyst / Institutional Investor Meet.
• The virtual one-to-one meeting will take place on March 3, 2026, at 4:00 PM.
• The interaction will be with Motilal Oswal AMC.
• Discussion will focus on industry and company-specific developments already in the public domain.

Key Numbers & Dates

• Analyst / Institutional Investor Meet: March 3, 2026, 04:00 PM (Virtual).

What Changes for the Business

• The meeting facilitates engagement with analysts and institutional investors.
• Discussions will be limited to information already available in the public domain.

⚠️ What Could Go Wrong (source-based)

• [Other] The schedule of the meeting may change due to exigencies from the investor or company.
• [Other] No unpublished price sensitive information (UPSI) is proposed to be shared during the meet.

What to Track Next

• Information regarding the investor meet is hosted on the Mastek website (www.mastek.com).

Summary

• Mastek (UK) Limited, a wholly-owned subsidiary of Mastek Limited, has secured a 5-year contract with the UK Home Office.
• The contract is valued at approximately £49 million (around $67 million+) and covers engineering, integration, and product development for the Home Office's biometrics systems.
• Mastek will support critical systems like the Biometrics Services Gateway and National DNA Database, enhancing services related to Passports, Visas, and Justice.

Key Numbers & Dates

• Contract Value: £49 million (approx. $67 million+)
• Contract Duration: 5 years (with 2 optional years)
• Announcement Date: February 27, 2026

What Changes for the Business

• Mastek will provide managed specialist engineering and cloud platform services to the UK Home Office.
• The company will focus on enhancing and maintaining key biometrics systems, enabling services for Passports, Visa, Study and Asylum routes, and DNA search.
• This contract signifies Mastek's deep domain knowledge in biometrics integration and advanced engineering capabilities within the UK public sector.

Summary

• Mastek Limited has scheduled an Analyst / Institutional Investor Meet.
• The virtual meet will take place on February 24, 2026.
• The company will interact with 360 One Asset Management.
• Discussions will cover industry and company-specific developments already in the public domain; no unpublished price sensitive information (UPSI) will be shared.

Key Numbers & Dates

• Analyst/Institutional Investor Meet: February 24, 2026 (Virtual, 12:30 PM)
• Announcement Date: February 23, 2026

⚠️ What Could Go Wrong (source-based)

• [Other] The schedule of the meeting may undergo change due to exigencies on the part of the investor or Company.

Summary

• Mastek Limited has rescheduled its analyst and institutional investor meet with ICICI Prudential AMC.
• The meeting was originally slated for February 21, 2026, and is now moved to February 22, 2026.
• The session will be held virtually and will focus on industry and company-specific developments already in the public domain.
• The company has confirmed that no unpublished price-sensitive information (UPSI) will be shared.

Key Numbers & Dates

• Original Analyst/Investor Meet Date: February 21, 2026 (As per previous intimation)
• Rescheduled Analyst/Investor Meet Date: February 22, 2026 (New schedule for the meet with ICICI Prudential AMC)
• Report Date: February 21, 2026 (Date of the intimation letter)
• Meet Timing: 01:30 PM

⚠️ What Could Go Wrong (source-based)

• [Other] The schedule of the meeting may undergo change due to exigencies on the part of the investor or Company.

News Crux

Mastek Limited has officially intimated the schedule for an Analyst / Institutional Investor Meet.

Key Events

• Analyst/Institutional Investor Meet Scheduled: Mastek Limited announced it has scheduled a virtual meeting with ICICI Prudential AMC on February 21, 2026, at 02:30 PM. The discussion will focus on industry/company-specific developments already in the public domain. The company has also highlighted that no unpublished price sensitive information (UPSI) will be shared during this interaction. This event is being conducted in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

News Crux

Mastek has been recognized as a 'Leader' in the Everest Group Digital Transformation Services for Mid-Market Enterprises PEAK Matrix® 2025, highlighting its AI-first approach and capabilities in driving digital transformation.

Guidance & Strategy

The recognition underscores Mastek's "AI-first, digital engineering, and cloud transformation" strategy, focusing on enabling mid-market enterprises to adopt AI at scale. The company emphasizes its niche expertise across cloud, data, AI, automation, and analytics. CEO Umang Nahata stated that Mastek is "uniquely positioned as a partner of choice for customers looking to modernize, transform, and grow with confidence" through AI-led digital application transformation.

Key Events

Mastek was recognized as a 'Leader' in the Everest Group Digital Transformation Services for Mid-Market Enterprises PEAK Matrix® 2025. This highlights customer confidence in Mastek’s AI-driven transformation capabilities and its ability to execute AI strategies effectively for mid-market businesses.

Outlook

The company's positioning and the recent recognition suggest a positive outlook for its AI-led digital transformation services in the mid-market segment. This is driven by the accelerating adoption of generative AI, agentic AI, and cloud-native architectures, where Mastek aims to be a partner of choice.

The news pertains to Mastek Limited's wholly-owned subsidiary, Mastek (UK) Limited, which has announced the expansion of its office in Leeds, UK. This strategic move is aimed at strengthening the company's capabilities in AI-led innovation and digital engineering, responding to increasing client demand for cloud, data, and AI-driven solutions. The expanded Leeds facility now offers a 100-seat capacity with provisions for further scaling. Mastek emphasizes this expansion as a reflection of its long-term commitment to the UK market and its contribution to regional economic growth through job creation and talent development. The company highlighted its ongoing collaboration with local partners, universities, and organizations to build future-ready digital and AI skills, aligning with the UK's Levelling Up agenda. This expansion reinforces Leeds as a key center for Mastek's UK operations and AI-enabled delivery.

Zensar Technologies Limited has issued a clarification to the stock exchanges (BSE and NSE) in response to a news item published on https://timesofindia.indiatimes.com on February 3, 2026. The report, captioned 'Zensar emerges frontrunner to buy Mastek in $900mn deal,' suggested potential acquisition talks. In its official communication, Zensar Technologies stated that as of February 3, 2026, there is no information or development that requires disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company further affirmed that it is not aware of any information that has not been announced to the Exchanges but which could potentially explain any movement in the company's trading. No regulatory or legal proceedings were reported as relevant.

Mastek Limited's Q3 FY26 earnings call transcript detailed a mixed performance for the quarter ended December 31, 2025. Operationally, the company experienced a 4.8% reduction in revenue on a constant currency basis, primarily due to seasonal furloughs in the UK and other public sector clients, alongside the completion of certain transformation programs and delays in the ramp-up of new ones. Despite this top-line pressure, Mastek demonstrated strong operational efficiency and cost management, leading to an improvement in its EBITDA margin by 60 basis points to 16.1%. This improvement was attributed to 43 basis points from AI-led operational efficiencies and 17 basis points from forex tailwinds. A one-time impact of INR 6.4 crores due to labor code changes was largely offset by a one-time credit from the reversal of onsite leave provisions.

In terms of growth drivers and outlook, Mastek highlighted its strengthening digital engineering capabilities, enhanced by AI, and its recognized position among mid-market performers. Its Oracle partnership continues to be strong, with the company being a top global partner for AI initiatives. The company is focusing on domain expertise in Healthcare and Life Sciences, and has recently renewed its strength in financial services, securing a circa $20 million deal in this sector. This strategic focus has led to significant growth in its order backlog; the total order backlog grew by over 30% year-over-year, and the 12-month order backlog increased by 18.4% YoY. The company is also transitioning towards more outcome-based contracts, which, while potentially impacting short-term revenue, are expected to build client confidence and lead to larger future engagements.

Financially, Mastek maintained a strong balance sheet, with its net cash position increasing to INR 346 crores from INR 135 crores in the previous quarter, reflecting INR 210 crores of operating cash added. Days Sales Outstanding (DSO) increased slightly to 84 days due to administrative delays in UK collections during the holiday season, but is expected to improve. The company declared an interim dividend of INR 8 per share. Looking ahead, management expressed confidence in improving bottom-line performance and anticipates FY27 to be a stronger year for growth compared to FY26, driven by increasing demand in Healthcare and Life Sciences and strategic growth in the US and AMEA regions. The company is not focused on building proprietary AI IPs but on service execution and leveraging platform IPs.

Mastek Limited has announced the publication of its unaudited consolidated and standalone financial results for the quarter ended December 31, 2025. This disclosure, made as per SEBI regulations, appeared in The Financial Express (English and Gujarati editions) and Mumbai Lakshadweep (Marathi edition). The report includes key financial metrics such as revenue and net profit.

Mastek Limited has formally disseminated information regarding the availability of an audio recording for its recent Earnings Conference Call. This call, conducted on January 21, 2026, convened investors and financial analysts to delve into the company's unaudited financial results for both the third quarter and the first nine months of the fiscal year 2025-26, which concluded on December 31, 2025. A specific web link has been provided by the company to facilitate access to this audio recording, thereby allowing stakeholders to listen to management's discourse and gain insights into the company's operational and financial standing.

The text of the announcement, however, does not furnish the detailed financial outcomes for the period. Specifics pertaining to revenue, EBITDA, PAT, margins, or EPS for the quarter or nine months are absent. Consequently, any analysis of YoY or QoQ performance, or comparisons against analyst estimates, cannot be derived directly from this notification.

Furthermore, the announcement does not present any forward-looking guidance or outlook offered by Mastek's management, nor does it highlight key discussion points from the concall such as strategy shifts, product wins, or cost-saving initiatives. The core financial deep dive elements, including income statement drivers, balance sheet composition (assets vs. liabilities, net debt, working capital, liquidity), cash flow generation (operating vs. net profit, CapEx, free cash), and key financial ratios (ROE/ROCE, liquidity ratios, debt-to-equity, interest cover), are not detailed in this release.

Additionally, there is no mention of significant corporate events like major order receipts, capacity expansions, product launches, penalties, or regulatory actions. Therefore, a comparative lens, assessment of long-term direction, opportunities, and risks also cannot be formed based solely on this announcement. Investors and analysts are directed to the provided audio recording for comprehensive details on these aspects of Mastek Limited's performance and future prospects.

SGL Resources Limited has submitted a certificate to the BSE Limited for the quarter ended December 31, 2025. This certificate, provided by the company's Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited (formerly Link Intime India Private Limited), confirms compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The RTA's confirmation states that all securities received from depository participants for dematerialisation during the quarter were duly processed, accepted or rejected, and confirmed to the depositories. Furthermore, the RTA confirmed that the dematerialised securities were listed on the stock exchanges and that the physical certificates were mutilated and cancelled after verification, with the depositories' names substituted in the register of members within the stipulated timelines. This filing represents a routine procedural compliance for listed entities.

Mastek Limited's Board of Directors, in a meeting held from January 20-21, 2026, approved the unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025. The board also declared an interim dividend for the financial year 2025-26.

For the third quarter of FY26 (ended December 31, 2025), Mastek reported total income of ₹92,657 lakhs, a 4.15% increase year-on-year (YoY) from ₹87,900 lakhs in Q3 FY25. Expenses were ₹78,538 lakhs, leading to a Profit Before Tax (PBT) of ₹14,119 lakhs, up 12.34% YoY from ₹12,569 lakhs. Net profit stood at ₹10,835 lakhs, an increase of 14.40% YoY from ₹9,471 lakhs in Q3 FY25. On a quarter-on-quarter (QoQ) basis, revenue decreased by 3.69% from ₹94,037 lakhs in Q2 FY26, while net profit grew by 11.18% from ₹9,745 lakhs in Q2 FY26. The consolidated PAT margin for Q3 FY26 was approximately 11.96%, an improvement from 10.89% in Q3 FY25.

For the nine months ended December 31, 2025, consolidated revenue was ₹276,075 lakhs, an 8.27% increase YoY from ₹254,981 lakhs in the prior year period. PBT rose by 12.09% YoY to ₹39,599 lakhs from ₹35,324 lakhs. Net profit for the nine months was ₹29,785 lakhs, a marginal 0.99% growth from ₹29,486 lakhs in the corresponding period of FY25. The consolidated PAT margin for the nine months was approximately 10.79%, down from 11.56% in the same period last year.

Standalone revenue for Q3 FY26 declined 3.23% YoY to ₹22,564 lakhs from ₹23,316 lakhs in Q3 FY25. However, standalone net profit surged 106.37% YoY to ₹2,819 lakhs from ₹1,366 lakhs in Q3 FY25, partly due to a significant positive impact from foreign currency transactions and translations and a restatement for a prior period amalgamation. For the nine months, standalone revenue decreased by 4.59% YoY to ₹67,296 lakhs, while net profit increased by 20.82% YoY to ₹14,528 lakhs.

The Board declared an interim dividend of ₹8 per equity share (160%) for FY 2025-26. The record date for this dividend is January 30, 2026, and payment will be made on or before February 17, 2026.

The financial results were subjected to a limited review by the statutory auditors, M/s. Walker Chandiok & Co. LLP. The report confirmed that based on the review, nothing came to their attention that causes them to believe the accompanying statements contain material misstatements and are prepared in accordance with Ind AS.

The report also includes details on segment revenue (UK & Europe, North America, AMEA) and other comprehensive income movements. Note 3 explains the restatement of comparative financial information due to the amalgamation of Mastek Enterprise Solutions Private Limited. Note 4 details exceptional items for prior periods, including impairment of goodwill and contingent consideration reversal. Note 8 discusses the potential impact of India's new Labour Codes. Basic EPS for Q3 FY26 was ₹34.97, up from ₹30.68 YoY. For the nine months, basic EPS was ₹95.49, compared to ₹94.50 YoY. The document contains detailed income statements but lacks specific balance sheet or cash flow data for comprehensive analysis of debt, working capital, or liquidity.

Mastek Limited announced its unaudited consolidated financial results for the quarter and nine months ended December 31, 2025, along with the declaration of an interim dividend.

Quarterly/Annual Results: For the quarter ended December 31, 2025 (Q3 FY26), Mastek reported consolidated revenue from operations of Rs. 905.68 crore, a 4.15% increase year-on-year (YoY). Consolidated net profit surged by 14.40% YoY to Rs. 108.35 crore. Profit before tax (PBT) grew 12.33% YoY to Rs. 141.19 crore. The basic Earnings Per Share (EPS) for the quarter stood at Rs. 34.97, showing a 14.00% YoY increase. Sequentially, Q3 FY26 revenue saw a 3.69% decline compared to Q2 FY26, but net profit increased by 11.19% QoQ.

For the nine months ended December 31, 2025 (9M FY26), consolidated revenue grew 8.27% YoY to Rs. 2,760.75 crore. However, net profit showed a modest increase of 1.01% YoY to Rs. 2,978.50 crore. Basic EPS for the nine-month period was Rs. 96.20, up 0.68% YoY.

Guidance & Concall Commentary: The provided text does not contain any management guidance or commentary from a conference call.

Financials:

• Income Statement: The consolidated revenue from operations for Q3 FY26 was Rs. 905.68 crore, up 4.15% YoY. The consolidated net profit for Q3 FY26 was Rs. 108.35 crore, up 14.40% YoY. Consolidated PAT margin improved to 11.69% in Q3 FY26 from 10.77% in Q3 FY25.
• Balance Sheet & Cash Flow: Details regarding the company's balance sheet and cash flow statements are not included in this announcement.

Key Events: The Board of Directors has declared an interim dividend of Rs. 8 per equity share (160%) for the Financial Year 2025-26. The record date for this dividend is January 30, 2026, and the payment is scheduled on or before February 17, 2026. Exceptional items were reported in the previous year's periods but were absent in the current quarter and nine-month period.

Outlook: No forward-looking statements or outlook for future performance are provided in the text.

Mastek Limited: Q3 FY26 Financial Results and Interim Dividend Announcement

Key Highlights

• Unaudited Financial Results: Mastek Limited announced its consolidated and standalone financial results for the quarter and nine months ended December 31, 2025.
• Interim Dividend: The Board of Directors declared an interim dividend of ₹8 per equity share (160%) for the Financial Year 2025-26.
• Payment Timeline: The interim dividend is scheduled to be paid on or before February 17, 2026.

Consolidated Financial Performance (Q3 FY26 vs Q3 FY25)

• Revenue from Operations: ₹90,568 lakhs, a year-over-year increase of 3.91% from ₹86,953 lakhs in Q3 FY25.
• Total Income: ₹92,657 lakhs, up 5.42% YoY from ₹87,900 lakhs.
• Profit Before Tax (PBT): ₹14,119 lakhs, a growth of 12.34% YoY from ₹12,569 lakhs.
• Net Profit: ₹10,835 lakhs, an increase of 14.40% YoY from ₹9,471 lakhs.
• Profit Before Tax Margin: Improved to 15.59% from 14.45% YoY.
• Net Profit Margin: Improved to 11.96% from 10.89% YoY.
• Exceptional Items: No exceptional items were recorded in Q3 FY26, compared to a gain of ₹398 lakhs in Q3 FY25.
• Basic EPS: ₹34.97, up 13.98% YoY from ₹30.68.

Consolidated Financial Performance (Nine Months FY26 vs Nine Months FY25)

• Revenue from Operations: ₹276,075 lakhs, an increase of 8.27% YoY from ₹254,981 lakhs.
• Total Income: ₹280,729 lakhs, up 9.29% YoY from ₹256,851 lakhs.
• Profit Before Tax (PBT): ₹39,599 lakhs, a growth of 17.34% YoY from ₹33,750 lakhs.
• Net Profit: ₹29,785 lakhs, a marginal increase of 1.01% YoY from ₹29,486 lakhs.
• Profit Before Tax Margin: Improved to 14.34% from 13.24% YoY.
• Net Profit Margin: Decreased to 10.79% from 11.57% YoY, indicating some pressure on profitability for the year-to-date period.
• Basic EPS: ₹96.20, up 0.68% YoY from ₹95.55.

Segment Performance (Quarter Ended December 31, 2025)

• UK & Europe Operations: Revenue was ₹59,890 lakhs, showing a significant YoY increase.
• North America Operations: Revenue was ₹20,333 lakhs, a year-over-year decline.
• AMEA Operations: Revenue was ₹10,345 lakhs, also showing a year-over-year decline.

Standalone Financial Performance

• Q3 FY26: Revenue was ₹22,564 lakhs (YoY -3.22%). Net profit increased significantly by 106.37% YoY to ₹2,819 lakhs, primarily due to prior period FX and dividend income impacts.
• Nine Months FY26: Revenue was ₹67,296 lakhs (YoY -4.59%). Net profit increased by 115.86% YoY to ₹7,747 lakhs, reflecting significant prior period adjustments.

Other Notes

• The financial results were prepared under Indian Accounting Standards (Ind AS).
• The Board meeting was held in Phoenix, Arizona, United States of America.
• No specific forward-looking guidance or management commentary beyond the results and dividend declaration was provided in the filing.

Dividend Details

• Interim Dividend Declared: ₹8 per Equity Share (160% of face value of ₹5).
• Record Date: Friday, January 30, 2026.
• Payment Date: On or before February 17, 2026.

Mastek announced its Q3FY26 financial results, showcasing year-on-year growth in revenue and a significant jump in net profit. The company highlighted strong performance in AI-led services, a robust order backlog, and improved sequential margins.

For Q3FY26, Mastek reported revenue from operations of ₹905.7 crore, a 4.2% increase year-on-year, though it saw a 3.7% decrease quarter-on-quarter. Operating EBITDA stood at ₹145.6 crore, with a margin of 16.1% (up 60 bps QoQ, down 10 bps YoY). Net Profit (PAT) grew impressively by 14.4% YoY to ₹108.4 crore, accompanied by a 149 bps QoQ expansion in PAT margin to 11.7%. Diluted EPS was ₹34.7. For the nine months ended December 31, 2025 (9MFY26), revenue from operations grew 8.3% YoY to ₹2,760.8 crore, while PAT saw a marginal 1.0% YoY increase to ₹297.8 crore.

Management noted the QoQ revenue decline was due to near-term headwinds like higher furloughs and project shifts, but emphasized operational discipline and AI-led efficiencies leading to healthy sequential EBITDA growth. The company sees strong demand in the Healthcare segment and AI-led solutions globally, closing over 26 new AI deals. The 12-month order backlog grew 7.0% sequentially and 24.3% YoY. 17 new clients were added, bringing the total active clients to 333. Management expressed confidence in delivering sustainable and profitable growth.

Financially, the company ended the quarter with a strong cash balance of ₹798.8 crore, an increase from ₹656.1 crore in the previous quarter. Operating cash flow of ₹210 crore was generated during the quarter. LTM ROE and ROCE were 14.6% and 15.8% respectively in Q3FY26, showing a slight decline from previous periods.

Key events included securing multiple strategic engagements during the quarter across various sectors and geographies, such as a three-year contract with a UK government agency for a national biometrics platform, a deal with a UK financial regulator, a strategic consulting engagement with a US asset manager, and work for England's Healthcare System. Many of these engagements leverage AI-led solutions and digital engineering. The company also declared an interim dividend of 160% or ₹8 per share.

The company remains focused on its AI-first, digital engineering strategy. Key growth drivers include AI-led services, expansion in sectors like Healthcare, and a strong pipeline in UK, US, and AMEA regions. While acknowledging near-term QoQ challenges, management is confident about long-term sustainable and profitable growth, leveraging its AI capabilities and expanding client base.

Mastek Limited announced its financial results for the third quarter and nine months ended December 31, 2025 (Q3 FY26). The company reported a consolidated revenue from operations of ₹905.7 crore for Q3 FY26, marking a 4.2% year-on-year (YoY) increase. Total income stood at ₹926.6 crore, up 5.4% YoY. On a sequential (QoQ) basis, revenue declined by 3.7% to ₹905.7 crore, attributed by management to higher furloughs, planned project go-lives, and a right-shift of engagements.

Profitability metrics showed significant year-on-year growth. Net Profit for Q3 FY26 was ₹108.4 crore, a 14.4% YoY increase. The Net Profit margin expanded by 92 basis points (bps) YoY to 11.7%. Sequentially, Net Profit grew by 11.2% QoQ with a 149 bps expansion in PAT margin. Operating EBITDA for the quarter was ₹145.6 crore, a 3.5% YoY rise, with the EBITDA margin at 16.1%, down 10 bps YoY but up 60 bps QoQ, reflecting operational discipline and AI efficiencies. Diluted Earnings Per Share (EPS) stood at ₹34.7 for the quarter.

For the nine months ended December 31, 2025 (9MFY26), revenue from operations grew 8.3% YoY to ₹2,760.8 crore, while Net Profit saw a marginal 1.0% YoY increase to ₹297.8 crore.

In terms of outlook, while management noted near-term headwinds and seasonal softness, they expressed confidence in their long-term AI-first strategy and ability to deliver sustainable, profitable growth. Demand in the Healthcare segment and AI-led solutions globally remains strong. The company added 17 new clients during the quarter, bringing the total active client count to 333.

Key operational highlights include a significant 24.3% YoY growth in the 12-month order backlog, reaching ₹2,658.5 crore ($295.8 million) as of December 31, 2025. The total order backlog increased by 36.6% YoY. The company declared an interim dividend of 160% or ₹8 per share. Mastek also reported an improvement in its S&P Global ESG CSA score to 82/100 from 74 the previous year.

Several strategic wins were secured during the quarter, emphasizing AI-driven solutions and digital engineering. These include contracts with a UK central government agency for a biometrics platform, a UK financial regulator, a US global asset manager for data platform modernization, an Australian local government for Oracle ERP Cloud implementation, England's Healthcare System for digital prevention services, a US dental products company for program management, and a global clinical research provider for an AI-powered data quality platform, among others. These engagements span across government, healthcare, financial services, and manufacturing sectors.

Mastek Limited announced on January 16, 2026, the approval and allotment of 1,722 equity shares of Rs. 5 face value each to eligible employees who exercised their vested options under its Employee Stock Option Plans (ESOPs). This corporate action has led to an increase in the company's paid-up share capital from Rs. 15,49,48,260 to Rs. 15,49,56,870, consequently raising the total outstanding shares to 3,09,91,374. The newly issued shares will rank pari-passu with the existing equity shares of the company in all respects. The disclosure has been made in compliance with SEBI (Share Based Employee Benefits) Regulations, 2014. This filing pertains solely to the ESOP allotment and does not contain any financial results, performance updates, or future outlook guidance.

Mastek Limited has informed the stock exchanges that its Board of Directors will meet on Tuesday, January 20, 2026. The primary agenda for this meeting is to consider and approve the unaudited financial results for the third quarter and the nine-month period ending December 31, 2025. A significant item on the agenda is the consideration for the declaration of an interim dividend for the Financial Year 2025-26. This announcement follows the company's recent Q2 FY26 performance, which indicated a consolidated revenue increase of 8.41% year-on-year to ₹94,037 lakhs. However, consolidated Profit After Tax (PAT) saw a decline of 24.27% to ₹9,745 lakhs, primarily attributed to increased income tax expenses and other operating costs. The company has been actively pursuing its AI-first strategy, securing over 25 new AI deals, and has seen its 12-month order backlog grow by 13.2% year-on-year to ₹2,484.3 crore.

Mastek Limited has announced that its step-down subsidiary, Mastek Systems (Malaysia) Sdn. Bhd., has initiated the process of voluntary winding up under the Companies Act in Malaysia. The company has emphasized that this subsidiary is not material to Mastek's overall operations. Consequently, the winding up is not expected to affect the parent company's consolidated revenue, business, or profitability. This disclosure is made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant SEBI circulars. The annexure to the filing provides details on the subsidiary's contribution, stating a turnover of ₹925 Lakhs and a net worth of ₹1046 Lakhs as of March 31, 2025, representing 0.27% and 0.42% of Mastek's consolidated figures, respectively. Mastek will inform the exchanges upon the completion of the winding-up formalities.

Mastek Limited has announced that its Board of Directors will convene on Tuesday, January 20, 2026. The primary agenda item for this meeting is to consider and approve the company's unaudited financial results, both standalone and consolidated, for the third quarter and the nine-month period ended December 31, 2025, prepared in accordance with Indian Accounting Standards (Ind AS).

Following the results announcement, Mastek will host an Earnings Conference Call for investors and analysts on Wednesday, January 21, 2026, at 6:30 PM IST. This call will provide a platform for management, including CEO Mr. Umang Nahata and CFO Mr. Deepak Kedia, to discuss the financial performance, business outlook, and answer participant queries.

The company has also informed that the trading window for Mastek's securities, which was closed from January 1, 2026, will remain closed until 48 hours after the financial results are made public, expected to be until January 23, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Mastek Limited announced its unaudited consolidated financial results for the quarter and half-year ended September 30, 2025.

Quarterly/Annual Results: For Q2 FY25, consolidated revenue grew 8.4% year-on-year to ₹94,037 lakhs (₹940.4 Cr). Profit After Tax (PAT) for the quarter decreased by 24.3% year-on-year to ₹9,745 lakhs (₹97.5 Cr). This decline was attributed to a higher effective tax rate and other operating costs. Basic EPS for the quarter was ₹31.48, down from ₹41.69 in the prior year's comparable quarter. For the half-year ended September 30, 2025, consolidated revenue increased by 10.4% YoY to ₹185,507 lakhs (₹1855.1 Cr), while PAT declined by 5.32% YoY to ₹18,950 lakhs (₹189.5 Cr).

Guidance & Concall Commentary: While specific Q2 FY25 guidance was not detailed, management commentary from related announcements indicated confidence in sustainable growth, particularly from UK/Europe traction and AI adoption.

Financials:

• Income Statement: Q2 FY25 consolidated revenue stood at ₹940.4 Cr (+8.4% YoY). Consolidated PAT was ₹97.5 Cr (-24.3% YoY).
• Balance Sheet: Consolidated net debt was ₹5,010 lakhs (₹50.1 Cr) as of September 30, 2025.
• Cash Flow: Improved operating cash flows for H1 FY26 were mentioned, alongside a transition to a near net-cash positive position. (Note: This commentary appears to refer to a future period or is a typo in the source text, as the financial results are for the period ending Sep 30, 2025).

Key Events:

• Leadership Changes: Sourabh Mukherjee was appointed President of Americas for Mastek Inc. Deepak Kedia was appointed Chief Financial Officer (CFO). Marc Berson was appointed to the Board of Directors of Mastek Inc.
• Framework Agreement: Mastek's UK subsidiary secured a 4-year supplier agreement under the NHS London Procurement Partnership’s (NHS LPP) Digital Technical Clinical Support (DTCS) Framework, positioning it for significant future revenue in UK healthcare.
• Annual General Meeting (AGM): The 43rd AGM was held virtually on September 23, 2025. Shareholders approved the adoption of audited standalone and consolidated financial statements for FY25. A total dividend of ₹23 per equity share was approved for FY24-25 (₹7 interim + ₹16 final).
• Partnerships: A strategic partnership was formed with KarbonWise to integrate AI-driven carbon accounting and ESG solutions.
• Awards: Mastek received the 'Best Enterprise-Wide AI Transformation (Mid-sized Co.)' award.
• Compliance: The company submitted its Business Responsibility and Sustainability Report (BRSR) for FY24-25 and provided compliance certificates regarding share dematerialization. Routine analyst/investor meets were conducted.

Mastek Limited has officially announced the allotment of 3,013 equity shares, each with a face value of Rs. 5, under its Employee Stock Option Plans (ESOPs) VI and VII. This corporate action, approved by the Stakeholder's Relationship Committee of the Board of Directors on December 30, 2025, signifies an increase in the company's paid-up share capital. Consequent to this allotment, Mastek's paid-up share capital has increased from Rs. 15,49,33,195 (representing 3,09,86,639 equity shares) to Rs. 15,49,48,260 (representing 3,09,89,652 equity shares). The company has confirmed that these newly issued shares will rank pari-passu with the existing equity shares of Mastek Limited in all respects. The disclosure was made in compliance with Regulation 10(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014.

Mastek Inc., a subsidiary of Mastek Limited, has announced the appointment of Marc Berson, currently Google's Head of Internal Systems (CIO), to its Board of Directors, effective January 1, 2026. This strategic move is intended to strengthen Mastek's North American footprint and integrate world-class Silicon Valley expertise into its strategic oversight, aligning with the company's 'Lead with AI' roadmap. Berson, who has spearheaded large-scale enterprise transformations at companies like Gilead Sciences, HP, IBM, and Philips, brings significant expertise in bridging complex systems and cutting-edge digital innovation. Mastek's CEO, Umang Nahata, commented that Berson's deep technology insight and practitioner-led experience will be invaluable for solidifying Mastek’s position as a preferred partner for delivering client ROI and driving high-impact, AI-driven business outcomes. Berson expressed enthusiasm for joining the board, citing clear alignment between Mastek’s AI-first strategy and evolving enterprise needs.

Mastek Limited has officially notified the stock exchanges regarding the closure of its trading window. This closure will be in effect from January 1, 2026, and will continue until 48 hours after the declaration and submission of the company's unaudited financial results for the third quarter and the nine months ending December 31, 2025. This action is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for trading by designated persons. The exact date for the Board Meeting to approve these financial results will be communicated in due course. This standard procedure aims to prevent any potential insider trading activities and ensure fair dissemination of price-sensitive information.

Mastek Limited has formally intimated the stock exchanges regarding a scheduled Analyst / Institutional Investor Meet. The meeting is slated for December 23, 2025, and will involve interaction with Renaissance Investment. The discussions are planned to focus on industry trends and company-specific developments that are already in the public domain. Crucially, Mastek Limited has explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during this engagement. The virtual meeting is scheduled for 12 Noon. This announcement is made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, and is considered a routine part of the company's investor relations activities.

Mastek Limited has formally notified the stock exchanges about a scheduled Analyst / Institutional Investor Meet. The meeting is slated to take place on December 22, 2025, and will be conducted virtually. The interaction will be with Nuvama Asset Management.

The primary agenda for this meeting is to discuss industry and company-specific developments that are already in the public domain. Crucially, Mastek Limited has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during this interaction. This ensures transparency and adherence to regulatory disclosure norms.

The company also noted that the schedule of the meeting may be subject to change due to exigencies on the part of the investor or the company. The information regarding this investor meet is also being hosted on the company's official website.

Mastek Limited has announced an upcoming Analyst / Institutional Investor Meet scheduled for December 19, 2025, with Carnelian Asset Management and Advisors. This virtual interaction is part of the company's regular investor engagement strategy.

Quarterly Performance: While this announcement does not include financial results, recent Q2 FY26 data indicates consolidated revenue grew 8.4% YoY to ₹940.4 crore. However, Net Profit saw a 24.3% YoY decline to ₹97.4 crore, primarily due to increased effective tax rates.

Outlook & Guidance: Management remains confident in sustainable growth, driven by AI adoption and continued traction in the UK/Europe markets. They have noted challenges from macro-economic uncertainties affecting client decision-making and contract tenures.

Financials: As of September 30, 2025, Mastek reported a consolidated net debt of ₹5,010 lakhs.

Key Events: The primary event in this update is the scheduled investor meet. Other recent developments include leadership changes, award wins for AI capabilities, and strategic partnerships. The company's 12-month order backlog stood at ₹2,484.3 crore, up 13.2% YoY.

Overall: The company is focused on leveraging its AI expertise and geographical diversification for future growth.

Mastek Limited has formally announced the schedule for an Analyst / Institutional Investor Meet with Quantum AMC, set to take place on December 18, 2025. The interaction will be conducted virtually, with the discussion centered on industry and company-specific developments that are already in the public domain. The company has explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during this meeting, adhering to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This meeting is part of Mastek's ongoing investor relations activities aimed at transparent communication with stakeholders regarding publicly known information.

Mastek Limited has formally informed the stock exchanges about the schedule for an Analyst / Institutional Investor Meet. The meeting is set to take place on December 16, 2025, with NT Asset Management. The interaction will be conducted virtually, with discussions focusing on industry trends and company-specific developments that are already in the public domain. Importantly, Mastek has reiterated its commitment to transparency and regulatory compliance by explicitly stating that no unpublished price-sensitive information (UPSI) will be shared during this engagement. This is a routine part of the company's ongoing investor relations activities.

Mastek Limited has formally notified the BSE and NSE about the schedule of an upcoming Analyst / Institutional Investor Meet. The meeting is scheduled to take place on December 15, 2025, and will be an interaction with B & K Securities. The discussion will focus on industry and company-specific developments that are already in the public domain. The meet will be conducted virtually at 12 Noon. Mastek Limited has explicitly stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during this interaction, adhering to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also noted that the schedule may be subject to change due to exigencies on the part of the investor or the company. The information is also being hosted on the company's website.

Mastek Limited has formally communicated the schedule for an Analyst / Institutional Investor Meet. The virtual meeting is set to take place on December 12, 2025, at 12 Noon, with Spark Global PWM Private Limited. The agenda for this interaction will revolve around discussing industry trends and company-specific developments that have already been disclosed to the public. A key aspect of this announcement is the company's explicit confirmation that no unpublished price-sensitive information (UPSI) will be shared during the meet, underscoring its commitment to regulatory compliance and transparent communication with stakeholders as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also noted that the schedule for this meet is subject to change due to potential exigencies.

Mastek Limited has formally notified the stock exchanges, BSE Limited and The National Stock Exchange of India Limited, regarding the schedule of an Analyst / Institutional Investor Meet. The meeting is set to take place on December 9, 2025, and will involve an interaction with Macquarie Group. Discussions during this meet are planned to cover industry trends and company-specific developments that are already publicly disseminated. A key point highlighted by the company is that no unpublished price-sensitive information (UPSI) will be shared during this interaction. This engagement is part of Mastek's routine investor relations activities and is conducted in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also reserves the right to reschedule the meeting if circumstances necessitate.

Mastek Limited has announced the cancellation of its analyst and institutional investor meet with Spark Global PWM Private Limited, which was scheduled to take place on December 8, 2025. This is a routine administrative update.

In recent financial disclosures for the second quarter ended September 30, 2025 (Q2 FY26), Mastek reported a consolidated revenue of ₹940.4 crore, marking an 8.4% year-on-year increase, driven by strong performance in the UK and Europe. However, consolidated Profit After Tax (PAT) saw a year-on-year decline of 24.3% to ₹97.4 crore, primarily due to an increased effective tax rate and other operating costs. The company's basic Earnings Per Share (EPS) for the quarter stood at ₹31.48, down from ₹41.69 in the prior year's corresponding quarter. For the half-year ended September 30, 2025, consolidated revenue grew by 10.40% year-on-year to ₹185,507 lakh, while PAT declined by 5.32% year-on-year to ₹18,950 lakh. The company also highlighted improved operating cash flows for H1 FY26.

Strategically, Mastek has been focusing on AI-driven services, securing over 25 new AI deals and receiving recognition for its AI transformation efforts. The company has also been appointed as a supplier on the NHS London Procurement Partnership's (NHS LPP) Digital Technical Clinical Support (DTCS) Framework, a significant development for its UK healthcare business. Leadership changes include the appointment of Mr. Deepak Kedia as the new Chief Financial Officer (CFO). Management has expressed confidence in achieving sustainable growth, supported by its UK/Europe traction and AI capabilities.

Mastek Limited has formally notified the stock exchanges about the schedule for an upcoming Analyst / Institutional Investor Meet. The meeting is set to take place virtually on December 8, 2025, at 3:00 PM IST, with Spark Global PWM Private Limited. The purpose of this interaction is to discuss industry and company-specific developments that are already in the public domain. A crucial aspect of this announcement is Mastek's explicit clarification that no unpublished price-sensitive information (UPSI) will be shared during the meeting. This proactive disclosure is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and ensures that the information is also available on the company's website.

Mastek Limited has formally announced the schedule for an upcoming Analyst / Institutional Investor Meet. The meeting is set to take place on December 5, 2025, and will be conducted virtually with Anand Rathi Share & Stock Brokers. The primary agenda for this engagement will be to discuss industry and company-specific developments that are already in the public domain. Importantly, Mastek Limited has explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during this interaction, adhering strictly to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also noted that the schedule might undergo changes due to exigencies on the part of the investor or the company. This announcement is a standard part of the company's investor relations process, aiming to maintain transparency by discussing only publicly disclosed information.

Mastek Limited has officially informed the stock exchanges about the allotment of 5,990 equity shares of Rs. 5 face value each under its Employee Stock Option Plans (ESOP) VI and VII. This decision was approved by the Stakeholder Relationship Committee on December 2, 2025.

Following this allotment, Mastek Limited's paid-up share capital has seen an increase. The total paid-up capital has risen from Rs. 15,49,03,245 (representing 3,09,80,649 equity shares) to Rs. 15,49,33,195 (representing 3,09,86,639 equity shares). The newly issued shares are identical in all respects to the existing equity shares of the company, ranking pari-passu. The company has made these disclosures in compliance with Regulation 10(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014.

Mastek Limited has announced its schedule for an upcoming Analyst / Institutional Investor Meet with Unifi Capital on November 20, 2025. The virtual meeting, set to commence at 03:30 PM IST, is part of the company's ongoing investor relations activities designed to foster transparency and communicate business developments. In line with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mastek has clearly stated that the discussions will be limited to industry trends and company-specific developments that are already in the public domain. Crucially, the company has emphasized that no unpublished price-sensitive information (UPSI) will be disclosed during this interaction. This proactive approach ensures that all stakeholders receive information in a regulated and equitable manner, preventing any potential market asymmetry. Such regular engagements with financial analysts and institutional investors are vital for the company to share its strategic direction, operational performance updates, and outlook with the investment community, thereby maintaining market confidence. Mastek's commitment to adherence to regulatory norms, as demonstrated by these disclosures, underscores its focus on good corporate governance. The company's website, www.mastek.com, will also host this information.

The press release from Mastek Limited, dated November 12, 2025, announces the immediate appointment of Mr. Deepak Kedia as the company's new Chief Financial Officer (CFO). Kedia, who brings over two decades of international finance leadership from companies like Motorola Solutions, Hewlett-Packard, and Wipro, will be responsible for Mastek’s global finance organization and will report directly to CEO Mr. Umang Nahata. His expertise encompasses strategic value creation, investor relations, capital allocation, P&L management, and digital finance transformation. Mastek highlights that his background in building high-performing teams and utilizing advanced analytics and AI-centric frameworks will accelerate the company’s 'Lead with AI' strategy and unlock stakeholder value. Mr. Nahata welcomed Kedia, emphasizing his financial acumen and strategic mindset in driving operational excellence and disciplined growth. Kedia expressed enthusiasm for Mastek's transformative phase and commitment to AI-led innovation, aiming to amplify value creation and enhance AI-enabled financial performance.

Mastek Limited has formally notified the stock exchanges about a scheduled Analyst / Institutional Investor Meet with Dharohar Capital. The virtual meeting is set to take place on November 13, 2025, at 03:30 PM. The discussions are intended to cover industry and company-specific developments that are already in the public domain. Crucially, Mastek Limited has assured stakeholders that no unpublished price-sensitive information (UPSI) will be disclosed during this interaction, underscoring its commitment to regulatory compliance and market transparency. The company also reserves the right to reschedule the meeting due to unforeseen exigencies. This event follows recent disclosures, including the Q2 FY25 earnings report approved on October 16, 2025, and the subsequent earnings conference call on October 17, 2025. The company's 43rd AGM was held on September 23, 2025, where dividends for FY24-25 were approved.

Mastek Limited, via a regulatory filing on November 11, 2025, informed BSE and NSE about a scheduled Analyst / Institutional Investor Meet. The meeting is slated for November 12, 2025, at 01:45 PM in Ahmedabad, and will be held in person. The interaction will be with Equirus Wealth, focusing on 'Industry/Company-specific developments already in the public domain'. A critical aspect of this disclosure is the company's explicit assurance that no unpublished price-sensitive information (UPSI) will be shared during the meet. This communication is made in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. The company also confirmed that this information is available on its website, www.mastek.com. The schedule is subject to potential changes due to exigencies from the investor or the company's side. Given that no new or non-public information is being disseminated, the direct market impact of this announcement is expected to be minimal for retail investors. It serves as a standard disclosure of planned investor engagement activities.

Mastek Limited, a global digital transformation services provider, has announced a significant leadership change with the appointment of Mr. Deepak Kedia as its new Chief Financial Officer (CFO) and Key Managerial Personnel (KMP). This decision was formally approved by the Board of Directors on November 11, 2025, based on the recommendations of the Nomination and Remuneration Committee and the Audit Committee, and is effective immediately from the same date.

Mr. Kedia brings a formidable background, boasting over two decades of international finance leadership experience across prominent global enterprises such as Motorola Solutions, Hewlett-Packard, and NTT Ltd. His career is marked by a successful track record in scaling high-growth businesses, leading strategic value-creation initiatives, and managing P&L, M&A, investor relations, capital allocation, and digital finance transformation. He is known for his ability to partner closely with Boards and senior leadership teams to drive enterprise strategy, strengthen governance, and enhance financial rigor in diverse multinational and high-growth technology environments. Prior to this role, he served as Chief Financial Officer at MarketsandMarkets and held multiple senior leadership positions at Motorola Solutions and Hewlett-Packard, where he successfully drove business turnarounds, margin expansion, and profitable growth.

Academically, Mr. Kedia is a Chartered Accountant and a CPA (Australia), complemented by executive education in Sustainable Finance from the University of Cambridge. He is recognized for his capabilities in building high-performing global finance teams, deploying advanced analytics and AI-driven decision frameworks, and championing disciplined financial management.

In addition to his role as CFO, Mr. Kedia has been designated as a Key Managerial Personnel authorized under Regulation 30(5) of the SEBI Listing Regulations to determine the materiality of an event or information and to make necessary disclosures to the stock exchanges. The appointment is in full compliance with Section 203 of the Companies Act, 2013, and relevant SEBI regulations. This strategic hiring signals Mastek's commitment to robust financial oversight and its ambition to leverage experienced leadership for sustained growth and strategic execution.

Mastek Limited has officially notified the stock exchanges regarding an upcoming Analyst / Institutional Investor Meet scheduled for November 10, 2025. This virtual meeting will involve interaction with 360 One AMC. The company has specified that the discussion will be limited to industry and company-specific developments already in the public domain. Crucially, Mastek Limited has affirmed that no unpublished price sensitive information (UPSI) will be shared during this event. As a result, this announcement does not contain details regarding quarterly or annual financial performance, revenue, profit, margins, EPS, or analyst EPS comparisons. There are no management guidance updates, outlook revisions, or commentary on growth drivers and risks provided. Similarly, the news does not offer insights into financial deep dives, balance sheet items, cash flow statements, key ratios, or comparative performance metrics. No significant orders, expansions, penalties, or product launches are mentioned. The primary purpose of this disclosure is regulatory compliance and investor engagement within predefined informational boundaries.

Mastek Limited has received the 'Best Enterprise-Wide AI Transformation (Mid-sized Co.)' award at the inaugural The Economic Times Making AI Work Awards 2025. This accolade highlights the company's significant advancements in integrating Artificial Intelligence across its internal operations, aligning with its 'Lead with AI' philosophy. The award recognizes Mastek's successful implementation of its ADOPT AI framework, designed to embed AI for Technology, AI for Business, and AI for Data into its core processes. This internal focus has not only enhanced Mastek's capabilities but also serves as a testament to its AI-driven solutions for clients.

According to CEO Umang Nahata, Mastek's strategy involves proactively adopting AI internally to maintain market leadership and drive innovation. The company has invested in upskilling its workforce, with over 3,600 employees now equipped with practical AI skills. This has fostered a culture of enterprise-wide innovation and digital maturity.

Mastek has leveraged AI across various internal functions, leading to measurable efficiency gains. Specific examples cited include:

• AI Amigo: Achieves up to 30% efficiency gains in software delivery and accelerates requirement-to-deployment cycles by 20%.
• Resolution.AI: Reduces incident resolution time by half, from 8 hours to 4 hours.
• Response.AI: Ensures 100% Service Level Agreement (SLA) compliance.

More than 60% of Mastek's internal workflows, spanning recruitment, sales, and IT operations, are now AI-enabled, utilizing tools such as Sales Copilot, Talent Genius, and Policy Helper. These initiatives collectively contribute to significant time savings, cost optimization, and productivity improvements.

The Economic Times Making AI Work Awards aim to spotlight organizations that transform AI concepts into tangible, responsible, and scalable solutions. Mastek, a global provider of enterprise AI, digital, and cloud services with a workforce of nearly 5,000 employees across over 40 countries, continues to champion ethical, scalable, and domain-driven AI adoption.

Mastek Limited has formally announced the schedule for an Analyst / Institutional Investor Meet, set to take place on November 3, 2025. The meeting, which will be conducted virtually, involves an interaction with WhiteOak AMC. The scope of the discussion is defined as industry-specific developments and company-specific information that is already within the public domain. A key highlight of this announcement is Mastek Limited's explicit confirmation that no unpublished price sensitive information (UPSI) will be shared during this engagement. This adherence to publicly available information ensures regulatory compliance. The meeting is scheduled for 03:30 PM, and the company has noted that the schedule may be subject to adjustments due to unforeseen circumstances. This event is primarily an informational update and does not involve new financial disclosures or strategic announcements beyond what is already known to the market.

Mastek Limited has entered into a strategic partnership with KarbonWise, an AI-powered sustainability solutions provider, as announced on October 31, 2025. This collaboration is set to accelerate their respective sustainability and ESG (Environmental, Social, and Governance) visions by integrating advanced capabilities across operations and value chains. The core objective of this alliance is to embed enhanced carbon accounting, comprehensive life-cycle emissions assessments, and critical Scope 3 emissions tracking into Mastek's client solutions. This strategic move will empower enterprises to pinpoint carbon-intensive hotspots more accurately and drive measurable progress towards net-zero commitments.
Mastek plans to leverage KarbonWise’s AI-driven platform and advisory services to translate sustainability goals into actionable and verifiable outcomes. This includes facilitating responsible ESG disclosures and embedding robust sustainability practices across Mastek's client base, its network of partners, and its own internal operations. KarbonWise brings specialized expertise in carbon management, life-cycle analysis, and credible ESG reporting, offering a platform that blends data-driven insights with strategic advisory to build resilient and transparent value chains.
The partnership aligns with Mastek’s commitment to innovation and its "Lead with AI" approach, enabling it to offer partner-enabled solutions that help enterprises navigate ESG compliance with greater confidence. Vimal Dangri, CHRO & General Counsel at Mastek, emphasized that this collaboration will allow clients to integrate sustainability into their core operations seamlessly, without impacting existing ERP systems, thereby transforming sustainability into a tangible source of business value. Arjun Vijayaragavan, CEO of KarbonWise, noted that the partnership combines their sustainability expertise with Mastek's digital transformation strengths to deliver advanced ESG solutions and support organizations in embedding sustainability into strategic decision-making. This initiative positions Mastek to address the growing global demand for comprehensive ESG solutions.

Mastek Limited announced its financial results for the quarter and half-year ended September 30, 2025 (Q2 FY26).

Financial Performance:

• Revenue: Operating revenue stood at INR 940 crores, an increase of 8.4% year-on-year (YoY) and 2.8% quarter-on-quarter (QoQ). Constant currency growth was 0.2%.
• Profitability: Operational EBITDA was INR 145.5 crores, reflecting a 1.7% YoY and 6% QoQ growth, with an operating EBITDA margin of 15.5%, up 50 basis points QoQ. Net profit for the quarter was INR 97.4 crores, up 6% QoQ. The YoY decline of 24% was due to an exceptional gain of INR 44 crores in the base quarter; on a normalized basis, net profit grew 14% YoY. The net profit margin was 10.2%.
• Order Book: The 12-month order backlog stood at $280 million, showing a 6.8% YoY and 2.2% QoQ growth.

Strategic Focus and Outlook:

• Key Strategies: Management highlighted a three-pronged strategy: continued focus on geographical diversity (UK, North America, APAC/Middle East), AI as a key growth driver across all businesses, and establishing leadership in the mid-market segment.
• AI Integration: The company is actively engaged in 'AI for Tech' (driving efficiency in service delivery) and exploring 'AI for Business' (driving transformation), with initial execution expected in early FY'27.
• Geographical Performance:
  • UK: Remains the strongest market, with robust demand in healthcare, secured government services (SGS), and private sector. A GBP 50 million-plus AI-led engineering services deal was secured for SGS.
  • North America: A new leadership team is in place, focusing on healthcare and life sciences. Macro uncertainties are leading to a right-shift in demand, with heightened S&M spend in anticipation of future growth.
  • APAC & Middle East (AMEA): Focus remains on healthcare, with a $7 million-plus AI-led healthcare transformation deal secured. DSO has improved significantly.
• Outlook: Management expressed optimism for a strong H2 FY26, despite macro uncertainties leading to slower decision-making and shorter contract tenures in some markets. They anticipate continued operational efficiency gains and growth driven by AI adoption.

Financial Health and Key Developments:

• Balance Sheet: Cash and cash equivalents stood at INR 656 crores. DSO improved to 80 days.
• Contract Dynamics: While the order book shows growth, management noted that macro uncertainties and client evaluation of AI impact are leading to slower decisions and preference for shorter-term contracts, particularly in North America.
• One-offs: A one-off revenue of approximately $0.5 million in AMEA was not recognized in the quarter due to pending paperwork, impacting regional margin temporarily.
• Leadership: A new CFO is expected to join early next month.
• Bank of England Work: Mastek is modernizing data for the Bank of England on a Databricks platform, crucial for fiscal decision-making. This is distinct from application modernization work by peers.
• Contract Mix: The current mix is 40% fixed price and 60% time & material. Discussions are ongoing regarding outcome-based pricing models, with efficiency gains expected to be shared with clients and reinvested in AI for business initiatives.

In compliance with SEBI regulations, Mastek Limited has announced the publication of its unaudited financial results for the second quarter of FY26, ending September 30, 2025. These results were featured in newspaper advertisements on October 17, 2025, specifically in The Financial Express (Mumbai edition), The Financial Express (Ahmedabad edition), and Mumbai Lakshadweep (Mumbai edition). The company also hosts these clippings on its official website for investor information.

Mastek Limited, via a notification dated October 17, 2025, has informed the stock exchanges about the availability of the audio recording for its earnings conference call. The call, held on the same day, was conducted to discuss the company's unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The Board of Directors had previously approved these financial results at a meeting held on October 16, 2025. The news provides a direct link to the audio recording of the conference call, allowing investors and analysts to review the discussions. However, this specific announcement does not contain the detailed financial figures, performance metrics (revenue, PAT, margins, EPS), management guidance, or commentary on growth drivers and risks. Similarly, there is no information provided regarding the company's balance sheet, cash flow, key ratios, or any significant corporate events like new orders, expansions, or regulatory updates. The primary focus of this communication is to make the post-results discussion accessible.

Mastek Limited announced its Unaudited Financial Results for the second quarter and half-year ended September 30, 2025 (Q2 FY26). The company reported consolidated revenue from operations of ₹940.4 crore, an increase of 8.4% year-on-year (YoY) and 2.8% quarter-on-quarter (QoQ). Operating EBITDA stood at ₹145.5 crore, up 1.7% YoY and 6.0% QoQ, with the EBITDA margin at 15.5%, a slight decrease from 16.5% YoY but an improvement from 15.0% QoQ. Net Profit (PAT) for the quarter was ₹97.4 crore, a significant decrease of 24.3% YoY but an increase of 5.9% QoQ, with the PAT margin at 10.2%. Diluted EPS was ₹31.2 for Q2 FY26. For the half-year ended H1 FY26, revenue grew 10.4% YoY to ₹1,855.1 crore, while PAT saw a decline of 5.3% YoY to ₹189.5 crore.

CEO Umang Nahata commented on the consistent performance, driven by strong traction in the UK and Europe, particularly in healthcare and government services. The company secured over 25 new AI deals during the quarter, with approximately 100 active AI engagements demonstrating tangible ROI. The 12-month order backlog grew by a healthy 13.2% YoY in rupee terms to ₹2,484.3 crore. Management expressed confidence in sustainable and profitable long-term growth, supported by a resilient pipeline and AI momentum. Key financial highlights include cash and cash equivalents of ₹656.1 crore as of September 30, 2025, and LTM ROE of 14.7% and LTM ROCE of 16.0%.

Key wins in Q2 FY26 included significant engagements with the UK's Central Government Department for Immigration Services, a US state's Gaming Control Board, a Middle Eastern foreign aid agency, and a US-based Digital Health company for AI-driven modernization. Mastek also received several industry recognitions, including awards from Oracle, ISG, Forrester, and Everest Group for its AI and digital engineering capabilities.

Mastek announced its un-audited financial results for the second quarter and half-year ended September 30, 2025 (Q2FY26). The company reported a revenue of ₹940.4 crore for Q2FY26, marking an 8.4% year-on-year (YoY) growth and a 2.8% quarter-on-quarter (QoQ) increase.

Operating EBITDA stood at ₹145.5 crore, showing a 1.7% YoY growth and a 6.0% QoQ increase, with the EBITDA margin improving to 15.5% QoQ from 15.0% in Q1FY26, aided by delivery efficiencies and cost optimization. Net Profit (PAT) for the quarter was ₹97.4 crore, a 5.9% QoQ growth but a 24.3% YoY decline from ₹128.7 crore in Q2FY25 (which was normalized for exceptional items to ₹85.6 crore). PAT margin was 10.2% QoQ, down from 14.7% YoY.

For the half-year ended H1FY26, revenue grew 10.4% YoY to ₹1,855.1 crore, while PAT saw a 5.3% YoY decline to ₹189.5 crore.

The company's 12-month order backlog showed strong momentum, growing 13.2% YoY to ₹2,484.3 crore as of September 30, 2025. Management expressed confidence in delivering sustainable, profitable long-term growth, driven by continued traction in the UK and Europe (especially in healthcare and government services), and strong performance in Digital Engineering and AI-led transformation programs.

Mastek highlighted securing over 25 new AI deals during the quarter, reinforcing its AI-first strategy. Several key wins were announced across various geographies and sectors, including a multi-year partnership with a UK government department for immigration services, AI-driven modernization for a US digital health company, and cloud transformation for a Middle-Eastern health system. The company also received numerous industry recognitions and awards for its AI capabilities and service excellence.

On the balance sheet, total cash and cash equivalents stood at ₹656.1 crore. LTM ROE was reported at 14.7% and LTM ROCE at 16.0%. Details on operating cash flow, CapEx, and free cash flow were not provided in this release.

Mastek Limited announced its unaudited consolidated financial results for the quarter and half-year ended September 30, 2025 (Q2 FY26 and H1 FY26) on October 16, 2025.

Financial Performance (Consolidated):

• Quarter Ended September 30, 2025 (Q2 FY26):
  • Revenue from operations grew by 8.41% year-on-year to ₹94,037 lakhs, compared to ₹86,739 lakhs in Q2 FY25. Quarter-on-quarter, revenue increased by 2.81% from ₹91,470 lakhs.
  • Profit After Tax (PAT) declined by 24.27% year-on-year to ₹9,745 lakhs, down from ₹12,865 lakhs in Q2 FY25. Quarter-on-quarter, PAT saw a modest increase of 5.87% from ₹9,205 lakhs.
  • Basic Earnings Per Share (EPS) for the quarter was ₹31.48, a decrease from ₹41.69 in the prior year's corresponding quarter. Diluted EPS was ₹31.24 (vs ₹41.22 YoY).
  • The company reported an exceptional gain of ₹1,176 lakhs in Q2 FY26.
  • PAT Margin compressed from approximately 14.83% in Q2 FY25 to 10.36% in Q2 FY26.
• Half-Year Ended September 30, 2025 (H1 FY26):
  • Revenue from operations increased by 10.40% year-on-year to ₹185,507 lakhs, up from ₹168,028 lakhs in H1 FY25.
  • Profit After Tax (PAT) for H1 FY26 was ₹18,950 lakhs, a decrease of 5.32% compared to ₹20,015 lakhs in H1 FY25.
  • Basic EPS for H1 FY26 stood at ₹61.23, down from ₹64.87 in H1 FY25.

Financial Health and Cash Flow:

• Balance Sheet: Mastek Limited has significantly improved its net debt position. As of September 30, 2025, the company reported total borrowings of ₹52,159 lakhs and cash & bank balances of ₹52,176 lakhs, resulting in a near net cash positive position (approximately ₹17 lakhs). This is a marked improvement from a net debt of ₹9,370 lakhs as of March 31, 2025.
• Cash Flow: For the six months ended September 30, 2025, Net cash generated from operating activities showed a substantial increase to ₹13,936 lakhs, up from ₹2,889 lakhs in the same period last year. Capital expenditure (CapEx) for H1 FY26 was ₹20,547 lakhs. The company transitioned from a negative free cash flow of -₹11,290 lakhs in H1 FY25 to -₹6,611 lakhs in H1 FY26.

Other Updates:
The results were reviewed by the Audit Committee and approved by the Board of Directors. The statutory auditors, M/s. Walker Chandiok & Co. LLP, have issued a limited review report on the accompanying consolidated unaudited financial results. No specific guidance, outlook, or forward-looking statements were provided in this announcement. The standalone financial results also showed a restatement due to a scheme of amalgamation.

Mastek Limited announced its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2025. The company's consolidated revenue from operations for Q2 FY25 grew by 8.4% YoY to ₹94,037 lakhs, driven by UK & Europe operations. However, consolidated Profit After Tax (PAT) declined by 24.3% YoY to ₹9,745 lakhs. This decline was primarily due to a significant increase in the effective tax rate, which rose to approximately 30.18% in Q2 FY25 compared to 22.22% in Q2 FY24. Profit Before Tax (PBT) showed a marginal YoY growth of 4.0% to ₹13,410 lakhs. Consolidated EPS for the quarter was ₹31.48, down 24.5% YoY. The company reported an exceptional gain of ₹1,176 lakhs in Q2 FY25. For the half-year ended September 30, 2025, consolidated revenue increased by 10.4% YoY to ₹185,507 lakhs, while PAT decreased by 5.3% YoY to ₹18,950 lakhs.

On a standalone basis, revenue from operations for Q2 FY25 decreased by 10.9% YoY to ₹21,837 lakhs, and PAT fell by 4.1% YoY to ₹7,520 lakhs. The standalone financial statements have been restated for comparative periods due to the merger with Mastek Enterprise Solutions Private Limited, effective April 1, 2024.

From a financial deep dive perspective, consolidated total assets stood at ₹403,392 lakhs as of September 30, 2025, an increase from ₹386,188 lakhs at the end of FY25. Total equity grew to ₹267,677 lakhs. The company's consolidated net cash position of ₹9,441 lakhs as of March 31, 2025, has shifted to a net debt of ₹5,010 lakhs as of September 30, 2025. Consolidated cash flow from operations saw a substantial increase, rising to ₹13,936 lakhs for H1 FY25 from ₹2,889 lakhs in H1 FY24.

Mastek Limited has officially notified the stock exchanges, BSE and NSE, regarding its compliance with a key SEBI regulation. The company submitted a certificate dated October 2, 2025, from its Registrar and Share Transfer Agent, KFin Technologies Limited, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate covers the financial quarter ending September 30, 2025. The core of the notification is that KFin Technologies has furnished all necessary details to the stock exchanges regarding securities dematerialized or rematerialized during the specified period. This is a standard, periodic compliance requirement for all listed companies to ensure transparency and efficiency in the handling of shares within the Indian securities market. The news does not contain any updates on quarterly or annual financial performance, management guidance, outlook, new orders, expansions, penalties, or any other material operational or strategic development. Therefore, its impact on investor decisions is minimal, reflecting its nature as a routine regulatory filing. The company's scrip code is 523704 on BSE and its symbol is MASTEK on NSE.

Mastek Limited has submitted a routine regulatory filing to the stock exchanges, BSE and NSE, on October 14, 2025. The primary purpose of this filing is to enclose a certificate confirming the company's compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025.

News Crux: The company has fulfilled its obligation to report on the status of securities dematerialization and rematerialization during the specified period.

Quarterly/Annual Results: This announcement does not contain any information related to the company's financial performance, such as revenue, profit, margins, or EPS for any quarter or fiscal year.

Guidance & Concall Commentary: No forward-looking statements, management guidance, or insights from investor calls are provided in this document.

Financials: The filing does not include any details pertaining to Mastek Limited's income statement, balance sheet, cash flow statement, or key financial ratios.

Key Events: The significant event is the submission of the compliance certificate by the Registrar and Share Transfer Agent, KFin Technologies Limited. This certificate attests that the necessary details regarding the movement of physical shares to dematerialized form (and vice versa) have been duly communicated to the stock exchanges. This is a standard procedure to ensure the smooth functioning of the demat system and adherence to SEBI's regulatory framework.

Outlook: No specific outlook or commentary on future business prospects is presented in this communication.

Mastek Limited has announced a Non-Deal Roadshow (NDR) scheduled for October 17, 2025, in Mumbai. The roadshow will involve management representatives conducting one-on-one and group meetings with institutional investors. The primary objective of these interactions is to discuss industry trends and company-specific developments that are already disclosed in the public domain. Mastek has explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during the event, ensuring compliance with regulatory norms. The meetings are scheduled to take place between 11:00 AM and 05:00 PM IST at a physical venue in Mumbai. This initiative is part of the company's ongoing investor relations activities.

Mastek Limited has officially announced the date for its Board Meeting to consider and approve the Unaudited Financial Results for the Second Quarter and half-year ended September 30, 2025. The meeting is scheduled for October 16, 2025. Following the results declaration, Mastek will host an Earnings Conference Call for investors and analysts on October 17, 2025, commencing at 9:00 AM IST and concluding by 10:00 AM IST. The conference call details include universal access numbers (+91 22 6280 1107 / 7115 8008) and several international toll-free numbers for regions including the USA, UK, Singapore, and Hong Kong. A DiamondPass™ link and a live audio webcast option are also provided for seamless participation. Mr. Umang Nahata, Chief Executive Officer of Mastek Group, will represent the management during the call. Participants are advised to dial in 10 minutes prior to the scheduled time. The company's website (www.mastek.com) will host the results and past conference call transcripts. This event is critical for investors to understand Mastek's recent financial performance and management's outlook for the coming periods.

Mastek Limited has issued a regulatory filing to the BSE and NSE, announcing that its Board of Directors will convene on Thursday, October 16, 2025. The principal agenda for this meeting is to consider, approve, and take on record the company's un-audited financial results for the second quarter and the half-year period that concluded on September 30, 2025. These results will be presented in both consolidated and standalone formats, prepared in accordance with Indian Accounting Standards (IndAS).

The announcement also provides updates regarding the company's trading window. In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and Mastek's internal code, the trading window has been closed for all designated persons since September 30, 2025. This closure will persist until 48 hours after the financial results are officially declared to the public. Consequently, the trading window is scheduled to reopen on October 19, 2025.

As the financial results themselves have not yet been published or approved, specific details regarding revenue, profit figures, margins, EPS, or any year-over-year/quarter-over-quarter comparisons are not available in this announcement. Similarly, management guidance, outlook, financial deep dive (balance sheet, cash flow), or any key ratios cannot be assessed from this notification. This filing serves purely as an intimation of the upcoming board meeting for results approval and the associated trading window management.

Mastek Limited, on October 08, 2025, formally announced the allotment of 5,932 equity shares of Rs. 5 face value each, issued under its Employee Stock Option Plans (ESOPs), namely ESOP Plan VI and ESOP Plan VII. This allotment was approved by the Stakeholder Relationship Committee of the Board of Directors and was made to eligible employees who exercised their vested options.

The primary impact of this issuance is on the company's share capital. Mastek's paid-up share capital has been adjusted from Rs. 15,48,73,585, represented by 3,09,74,717 equity shares, to Rs. 15,49,03,245, represented by 3,09,80,649 equity shares. The increase in share capital amounts to Rs. 29,660, reflecting the face value of the newly allotted shares.

The company has confirmed that these 5,932 equity shares will rank pari-passu with the existing equity shares of Mastek Limited in all respects, ensuring no dilution of rights for existing shareholders. The detailed disclosure, made in compliance with Regulation 10(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014, provides specific details on the ESOP plans, the number of shares issued, and their distinctive numbers. The exercise price and premium per share details are also provided in an annexure, indicating varying terms for different tranches of options exercised.

Mastek Limited announced a significant leadership transition with the appointment of Vimal Dangri as the new Chief Human Resources Officer (CHRO), effective September 24, 2025. Dangri succeeds Arvind J in this role and will continue to report to CEO Umang Nahata.

Dangri, a law graduate, brings over 24 years of extensive experience in legal advisory, project management, policy making, organizational change, process excellence, and problem-solving. His appointment integrates human resources leadership with his existing responsibilities as General Counsel & Chief Risk Officer. In this expanded capacity, he will continue to oversee Mastek’s strategies and actions across legal, risk, compliance, ethics, corporate governance, quality, and sustainability, while also driving key business enablers such as cost efficiencies and structural simplification.

CEO Umang Nahata expressed confidence in Dangri's leadership, noting his proven track record in legal, risk, and governance has delivered meaningful results. Nahata emphasized Dangri's people-centric approach as crucial for strengthening Mastek's bold and inclusive culture and supporting growth ambitions.

Dangri himself stated his honor in taking on the CHRO role, reaffirming Mastek's culture of empowering its people for growth and innovation. He looks forward to working with leaders and teams globally to enhance people practices and elevate employee experiences. Mastek, a global AI-first digital engineering and cloud transformation partner with a presence in over 40 countries and nearly 5,000 employees, aims to leverage this leadership transition to further bolster its organizational strength and employee development.

Mastek Limited has informed the stock exchanges about a scheduled Analyst / Institutional Investor Meet with Axis MF on September 30, 2025, at 03:30 PM in Mumbai. The meeting, to be held in person, will focus on industry and company-specific developments that are already publicly available. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during this interaction. This is a routine disclosure under SEBI regulations. The schedule is subject to change based on exigencies. The information has also been hosted on the company's website. This event does not provide new financial insights or guidance but serves as a platform for interaction with existing public information.

Mastek, an AI-first digital engineering and cloud transformation partner, has announced the successful completion of its AI-powered Oracle HCM Cloud and Redwood UX/UI implementation for Harmony Australasia, a global mining leader. The project, which took 56 weeks, resulted in a unified HR platform covering five legal entities and two business units for Harmony Australasia's operations in Australia and Papua New Guinea. The scope included the deployment of Oracle Recruiting Cloud (ORC), Core HR, Learning, Talent, Compensation, and HR Helpdesk, all executed in a single go-live event. This transformation addresses the demanding operational and compliance requirements of the mining sector by creating a smart, streamlined HR function. Key benefits realized include unified HR data for reliable analytics and compliance, greater efficiency through automation, faster decision-making with real-time insights, simplified workforce mobility, and improved employee engagement via user-friendly mobile tools. Management from both companies expressed satisfaction, with Mastek highlighting the project's on-time completion with zero escalations as a benchmark for HR excellence. Mastek is a global provider of enterprise AI, digital, and cloud services with a significant global presence and workforce.

Hi5 Youth Foundation has filed a prior intimation under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding its intention to acquire 500,000 equity shares, representing 1.62% of the total equity share capital of Mastek Limited. These shares are to be acquired from Mr. Sundar Radhakrishnan, who is a promoter of Mastek Limited. The proposed transaction, slated for on or after September 19, 2025, is structured as a gift or donation without any consideration. Consequently, Hi5 Youth Foundation will be disclosed as a member of the 'Promoter and Promoter group' of Mastek Limited. The acquisition falls under Regulation 10(1)(a)(iii) of the SEBI (SAST) Regulations, 2011, which provides an exemption from making an open offer for such inter-se transfers within the promoter group. The disclosure also notes that the volume-weighted average market price for the 60 trading days preceding the notice was ₹2507.11 on the NSE. Historical disclosures regarding compliance with Chapter V of the Takeover Regulations and confirmation of no encumbrances on promoter shareholdings were also included.

Mastek Limited, via a regulatory filing dated September 26, 2025, has announced the closure of its trading window. This measure is implemented in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's "Code for Regulating, Monitoring and Reporting of trading by designated persons and their immediate relatives."

The trading window for dealing in the shares of Mastek Limited will be closed from September 30, 2025. It will remain shut until 48 hours after the declaration and submission of the unaudited financial results for the second quarter ending September 30, 2025, to the stock exchanges.

The company has duly informed its Designated Persons about this closure as per its Code of Conduct. The specific date for the Board Meeting to consider and approve these financial results will be communicated by the company in due course. This is a standard procedure to prevent insider trading activities around the announcement of financial results.

Mastek Limited has formally notified the stock exchanges, BSE Limited and The National Stock Exchange of India Limited, regarding an upcoming Analyst / Institutional Investor Meet. The interaction is scheduled for September 26, 2025, with Fidelity International Ltd. The meeting will be conducted virtually and is set to commence at 04:00 PM IST.

The nature of the discussion has been clearly defined as "Industry/Company-specific developments already in the public domain." This is a crucial point, as Mastek Limited has explicitly stated that "no unpublished price sensitive information (UPSI) is proposed to be shared by the Company during the aforesaid investor meet." This clarification suggests that the meeting is intended for routine investor engagement, information reinforcement, and maintaining relationships with institutional investors, rather than for the disclosure of new material financial or strategic information that could influence investment decisions.

The company has also included a standard disclaimer that the schedule of the meeting may be subject to change due to exigencies on the part of the investor or the company. The intimation is made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, and the information is also available on Mastek's official website, www.mastek.com.

No financial results, performance metrics, forward-looking guidance, specific orders, expansions, or regulatory actions are part of this announcement. Therefore, the direct impact on Mastek Limited's stock performance from this specific news event is anticipated to be minimal, primarily serving as a standard disclosure for investor relations.

Mastek Limited has officially announced significant changes within its Senior Management Personnel (SMP) through a regulatory filing dated September 24, 2025. Mr. Arvind Jonnalagadda, the Global Chief Human Resource Officer (CHRO) of the company, has tendered his resignation, which will be effective from the close of business hours on October 16, 2025. Mr. Jonnalagadda's departure is attributed to his decision to pursue career opportunities outside of Mastek. He will continue to be associated with the company until his last day to ensure a smooth handover of responsibilities.

In light of Mr. Jonnalagadda's resignation, Mastek Limited has appointed Mr. Vimal Dangri to additionally hold the position of Chief Human Resources Officer. Mr. Dangri currently serves as the General Counsel and Chief Risk Officer of the company. His additional charge as CHRO is effective from September 24, 2025. Mr. Dangri brings over 24 years of experience, leading Mastek's legal, risk, compliance, ethics, corporate governance, and sustainability initiatives. He previously held senior roles at Firstsource Solutions Limited. The company has provided the necessary disclosures as per SEBI regulations, confirming that there are no other reasons for Mr. Jonnalagadda's resignation beyond pursuing external career paths and no conflicts of interest for Mr. Dangri's new role. This announcement is primarily a governance and personnel update, with no immediate financial performance data, guidance, or outlook shared in this filing.

Mastek Limited conducted its 43rd Annual General Meeting (AGM) on Tuesday, September 23, 2025, via video conferencing. All six proposed resolutions were approved by the shareholders with the requisite majority. The resolutions included:

1. Adoption of Audited Financial Statements: The audited standalone and consolidated financial statements for the financial year ended March 31, 2025, along with the Board and Auditor's reports, were adopted. This resolution received near-unanimous support.
2. Dividend Declaration: Shareholders confirmed the interim dividend of ₹7.00 per equity share and declared a final dividend of ₹16.00 per equity share for the Financial Year 2024-25. This also saw overwhelming approval.
3. Re-appointment of Mr. Ashank Desai (Director retiring by rotation): An ordinary resolution for the re-appointment of Mr. Ashank Desai, a Non-Executive/Non-Independent Director, was passed. However, this resolution saw 4.6321% of votes against it, with institutional shareholders contributing a significant portion of the dissent (9.6323%).
4. Continuation of Mr. Ashank Desai as Director: A special resolution to approve the continuation of Mr. Ashank Desai as a Non-executive Director beyond the age of seventy-five years was passed with 99.1784% in favour. Some opposition was noted from institutional shareholders (1.7033%).
5. Re-appointment of Mr. Suresh Choithram Vaswani (Independent Director): A special resolution for the re-appointment of Mr. Suresh Choithram Vaswani as an Independent Director for a second term was approved. This resolution received 83.4825% votes in favour, but a substantial 16.5178% voted against it, with institutional shareholders showing significant dissent at 43.5792%.
6. Appointment of Secretarial Auditors: M/s. P. Mehta & Associates were appointed as Secretarial Auditors for a term of five years, receiving broad shareholder approval.
   The meeting was conducted transparently, with voting results meticulously documented and reported by M/s. P. Mehta & Associates, the appointed scrutinizer. The company has ensured compliance with SEBI Listing Regulations and MCA circulars concerning virtual AGMs. No specific financial performance figures or forward-looking guidance were discussed as part of this voting disclosure.

This document summarizes the proceedings of Mastek Limited's 43rd Annual General Meeting (AGM) held virtually on September 23, 2025. The AGM primarily focused on shareholder approvals and procedural matters. Key outcomes included the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2025. While specific financial figures were not detailed in this summary, the Board and Auditors' reports on these statements were taken as read.

During the meeting, the Chairman, Mr. Ashank Desai, and the CEO, Mr. Umang Nahata, provided a brief overview of the company’s performance and industry trends for the reviewed financial year and the current period. No specific future guidance was disclosed.

Shareholders approved significant resolutions, including the confirmation of an interim dividend of ₹7.00 per equity share and the declaration of a final dividend of ₹16.00 per equity share for the Financial Year 2024-25. This results in a total dividend payout of ₹23.00 per share for FY24-25.

Furthermore, resolutions for director re-appointments were passed: Mr. Ashank Desai was re-appointed as a Director liable to retire by rotation and also approved for continuation beyond seventy-five years of age. Mr. Suresh Vaswani was re-appointed as an Independent Director for a second term of three years.

The appointment of M/s. P. Mehta & Associates as Secretarial Auditors for a term of five consecutive years, along with their remuneration, was also approved. The AGM was conducted via Video Conferencing/Other Audio-Visual Means (VC/OAVM) in compliance with regulatory norms, with provisions for remote e-voting and voting during the meeting. The company will separately intimate the voting results to the stock exchanges.

NA

NA

NA

Mastek Limited, through a regulatory filing on September 19, 2025, has announced an upcoming Analyst / Institutional Investor Meet. This virtual meeting is scheduled for September 22, 2025, and will involve interaction with ICICI Prudential AMC. The core purpose of the discussion, as stated by the company, is to cover industry and company-specific developments that are already in the public domain. Crucially, Mastek Limited has explicitly clarified that no unpublished price sensitive information (UPSI) will be disclosed during this meeting. This measure is designed to maintain transparency and avoid any potential market impact from non-public information. The company also noted that the schedule is subject to change due to unforeseen circumstances. This event represents a standard investor outreach initiative by Mastek.

Mastek Limited has announced the resignation of M/s. Grant Thornton UK LLP as the statutory auditor of its material subsidiary, Mastek Systems Company Limited. The resignation is effective from September 18, 2025. According to the auditor's letter dated September 17, 2025, the reason for their ceasing to hold office is that they were not reappointed following an audit tender process. Grant Thornton UK LLP has explicitly stated that there are no matters connected with their resignation which they consider should be brought to the attention of the members or creditors of the company. The company has submitted the required disclosures as per SEBI regulations, confirming that no other material reasons exist for the resignation. The previous audit report for the financial year ended March 31, 2024, was signed on December 18, 2024. This event is a routine procedural update and does not indicate any adverse findings or immediate financial impact on Mastek Limited.

Mastek Limited, via an intimation dated September 18, 2025, reported the resignation of Grant Thornton UK LLP as the statutory auditor for its material subsidiary, Mastek (UK) Limited. The resignation is effective from September 18, 2025. The auditor, Grant Thornton UK LLP, provided its resignation letter on September 17, 2025. The primary reason for their cessation of office, as per Section 519 of the Companies Act 2006, is that they were not reappointed after an audit tender process. Grant Thornton UK LLP explicitly stated that there are no matters connected with their ceasing to hold office which they consider should be brought to the attention of the members or creditors of Mastek (UK) Limited. They also confirmed no other material reasons for their resignation beyond the non-reappointment. The auditor was initially appointed in FY 2020 and their term was based on yearly re-appointment. The latest audit report signed by them was for the financial year ended March 31, 2024, dated March 31, 2025. The company has filed this disclosure in compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Mastek Limited has issued a clarification to the BSE in response to a query regarding an increase in the trading volume of its securities. The company, through its Company Secretary & Compliance Officer, Reena Raje, has stated that there is no unpublished price-sensitive information (UPSI) or event that has become due for disclosure to the stock exchanges as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mastek Limited further clarified that any movement observed in the volume of its shares is purely market-driven. The company affirmed its commitment to consistently making required disclosures and adhering to SEBI regulations. This clarification comes in response to BSE's email dated September 18, 2025.

Mastek Limited has been recognized with the 'Voice of the Customer Honor – Value Excellence' award at the Everest Group Elevate Honors™ 2025. This prestigious recognition is based on independent, fact-based research and the feedback from over 400 customers who scored Mastek in the top percentile for customer service excellence, client management, ease of doing business, and proactive engagement.

The award signifies Mastek's consistent delivery of high-impact value and its collaborative approach with clients, leveraging innovation, technical expertise, and alignment with strategic business priorities. It validates the company's track record in generating strategic results and accelerating value realization for its customers.

Umang Nahata, CEO of Mastek, expressed pride in receiving the award from Everest Group, a leading global research and advisory firm. He stated that the recognition reflects the trust customers place in Mastek and validates their approach of aligning with client businesses to deliver meaningful outcomes. Nahata also highlighted Mastek's strategic focus on the AI wave, aiming to 'Lead with AI' with dedicated AI for Tech, AI for Business, and AI for Data initiatives, supported by over 3500 trained AI professionals.

Mastek, an AI-first digital engineering and cloud transformation partner, operates in over 40 countries. The company leverages its expertise in AI, Data & Analytics, cloud, and digital engineering to help enterprises streamline revenue, optimize operations, and unlock new opportunities. Through strategic partnerships with leaders like Oracle, AWS, Microsoft, Snowflake, and Salesforce, Mastek assists customers in modernizing systems, enhancing talent collaboration, and driving scalable growth. The company aims to enable clients to achieve measurable and sustainable returns on technology investments, serving sectors such as Public Sector, Healthcare, Retail, Manufacturing, Higher Education, and Financial Services.

The primary news concerns Mastek Limited's promoter group shareholding changes and compliance filings.

Acquisition by Gift: Hi5 Youth Foundation, an entity in which promoter Mr. Sundar Radhakrishnan holds a 60% stake, intends to acquire 500,000 equity shares, representing 1.62% of Mastek Limited's total equity share capital. This acquisition is proposed to occur by way of gift without any consideration, on or after September 19, 2025. This transaction is classified as an inter-se transfer among promoters, thereby qualifying for exemption from making an open offer under Regulation 10(1)(a)(iii) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing notes the Volume Weighted Average Market Price (VWAP) for the 60 trading days preceding the notice date as ₹2507.11. Post-acquisition, Mr. Sundar Radhakrishnan's holding will reduce from 4.22% to 2.60%, while Hi5 Youth Foundation will hold 1.62%. The total promoter and promoter group shareholding remains at 35.79%.

SEBI Compliance Filings: Mastek Limited has also submitted a series of declarations confirming compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. These declarations, made on behalf of the Promoters/Promoter Group and Persons Acting in Concert (PACs) and signed by promoter Mr. Ashank Desai, cover the financial years 2022-23 (filed April 11, 2023), 2023-24 (filed April 10, 2024), and 2024-25 (filed April 07, 2025). Each declaration confirms that no promoter, promoter group member, or PAC has made any encumbrance (such as pledging) on their shareholding in Mastek Limited during the respective financial years.

Absence of Financial Data: These documents exclusively pertain to regulatory disclosures and do not contain any information regarding Mastek Limited's quarterly or annual financial results, performance metrics (revenue, PAT, margins, EPS), management guidance, outlook, balance sheet details, cash flow statements, or key financial ratios. Consequently, no comparative analysis of financial performance or impact assessment based on financial metrics can be made from this news.

Mastek Limited announced that its wholly-owned subsidiary, Mastek (UK) Limited, has been named a supplier on the NHS London Procurement Partnership’s (NHS LPP) Digital Technical Clinical Support (DTCS) Framework. This is a four-year framework agreement, replacing the former Clinical Digital Professional Services (CDPS) agreement, designed to provide trusted access to clinical digital support services for NHS organisations and wider public healthcare bodies across the UK. The DTCS framework aims to accelerate the procurement of high-quality clinical digital solutions and infrastructure, covering clinical system architecture, development, integration, implementation, and digital consultancy. Under Lot 1 of the agreement, Mastek will deliver services including Cloud Hosting, Environment Build, and ongoing Operations and Maintenance to support scalable, secure, and integrated clinical platforms. Abhishek Singh, President UKI & Europe, Mastek, stated, 'Mastek securing place on the DTCS framework reinforces our continued focus on supporting the UK public sector and healthcare ecosystem. With a strong track record of delivering mission-critical digital services across NHS Trusts, Integrated Care Systems (ICSs), and Arms Length Bodies, we help NHS organisations modernise legacy systems, adopt cloud-native architectures, and build secure, patient-centric digital environments.' The framework is intended to introduce greater flexibility, encourage SME participation, and broaden the scope for clinical digital professional services. This appointment underscores Mastek's strategic focus on the UK public sector and healthcare market, leveraging its expertise in AI-first digital engineering and cloud transformation. No financial figures for the framework were disclosed, but it represents a significant opportunity for future revenue generation.

The provided text contains public notices from various Indian companies regarding upcoming corporate events and regulatory compliance. Key announcements include the scheduling of Annual General Meetings (AGMs) by companies such as Advani Hotels & Resorts India Limited (September 1, 2025), 1point1 Solutions Limited (September 26, 2025), Choksi Imaging Limited (September 29, 2025), Yamini Investments Limited (September 25, 2025), Venturatextiles Limited (September 30, 2025), and Nivi Online Limited (September 26, 2025). Detailed procedures for shareholders to participate in these AGMs via e-voting, including deadlines and platforms like NSDL and Link Intime, are provided. A significant recurring theme is the impending transfer of shares with unclaimed dividends for seven or more consecutive years to the Investor Education and Protection Fund (IEPF) Authority, as mandated by the Companies Act, 2013, and SEBI regulations. Companies including Mastek Limited, Advani Hotels & Resorts India Limited, 1point1 Solutions Limited, Choksi Imaging Limited, Yamini Investments Limited, Pipeline Infra Limited, Venturatextiles Limited, and City Union Bank are issuing these notices. Additionally, Pipeline Infra Limited has announced the redemption of Non-Convertible Debentures (NCDs) maturing in September 2025. No financial performance data, guidance, or outlook commentary is present in these regulatory notices.

Mastek Limited's US-based step-down subsidiary, Mastek Inc., has announced the appointment of Sourabh Mukherjee as its President for the Americas region, effective immediately. This strategic leadership appointment aims to bolster Mastek's growth and client engagement in the critical Americas market. Mukherjee brings over two decades of extensive global IT services experience, with a specialization in digital engineering, cloud transformation, and deep expertise across sectors like Healthcare & Life Sciences, Manufacturing, and Retail. He has a proven track record in leading hyper-growth initiatives, managing P&L, and fostering strategic partnerships, which will be instrumental in shaping Mastek's strategy in the region. Mastek's CEO, Umang Nahata, expressed confidence in Mukherjee's ability to drive future growth, emphasizing his leadership and domain expertise. Mukherjee's prior experience includes leadership roles at Cognizant and Wipro. Mastek, a global AI-first digital engineering and cloud transformation partner with a presence in over 40 countries, expects this appointment to enhance its market presence and deliver meaningful outcomes to clients in the Americas.

Mastek Limited has announced the details for its 43rd Annual General Meeting (AGM), scheduled to be held via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has published newspaper clippings containing essential information for shareholders, including procedures for remote e-voting, the record date for the payment of the final dividend (September 23, 2025), and a special window for re-lodging transfer requests for physical shares. The announcement also mentions the initiation of the "Saksham Niveshak" campaign by the Investor Education and Protection Fund Authority. This communication is aimed at ensuring shareholders are informed about the AGM proceedings and related corporate actions.

Shree Pushkar Chemicals & Fertilisers Ltd. has announced a final dividend of ₹2.00 per share, representing a 20% payout for the financial year 2024-25. The company has set September 20, 2025, as the record date for this dividend payment. Additionally, the company's 32nd Annual General Meeting (AGM) is scheduled to be held on September 29, 2025, at 3:00 PM. Mastek Limited has issued a public notice regarding its 43rd AGM, including details on remote e-voting and the record date for dividend payment. Sparc Electrex Limited has also announced its upcoming 36th and 61st AGMs, providing information on the meeting schedule, e-voting procedures, and updates for shareholders' email addresses.

Mastek Limited has made a regulatory filing on August 29, 2025, to the BSE and NSE, intimating them as per Regulation 30 and 36(1)(b) of the SEBI Listing Regulations, 2015. The company has dispatched its Annual Report for the financial year 2024-25 to its members who have not registered their email addresses with the company or depositories.

The Annual Report for FY2024-25, along with the Notice convening the 43rd Annual General Meeting (AGM), is accessible via a web link provided on the company's website, www.mastek.com. The exact path for accessing the report is specified as 'Investors → Annual Report 2024-25'. Additionally, the report is also available on the websites of the stock exchanges, www.bseindia.com and www.nseindia.com. Shareholders interested in obtaining a physical copy can request it by emailing investor_grievances@mastek.com.

The 43rd AGM of Mastek Limited is scheduled to be held on Tuesday, September 23, 2025, at 5:00 PM (IST). The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM), in compliance with current circulars from the Ministry of Corporate Affairs and SEBI.

The company encourages shareholders to update their email addresses with the Company/Depository/RTA to ensure easy and direct access to company documents and records. Shareholders holding shares in electronic mode are advised to update via their Depository Participants (DPs), while those holding shares in physical mode can register their email by sending a request to investor_grievances@mastek.com or einward.ris@kfintech.com.

Mastek Limited, through a board meeting held on August 29, 2025, has approved the appointment of Ms. Reena Raje as the new Company Secretary and Compliance Officer. This appointment is effective from September 1, 2025. Ms. Raje, a qualified Company Secretary with a law degree and over 17 years of professional experience, previously worked with Larsen & Toubro Limited and Nitco Limited, focusing on corporate governance, legal advisory, compliance, and regulatory matters. She has expertise in secretarial transactions including mergers, acquisitions, buy-backs, FEMA, and SEBI regulations. Concurrently, Mr. Dinesh Kalani, the current Company Secretary & Compliance Officer, will cease his tenure at the close of business hours on August 31, 2025, upon attaining superannuation. The Board expressed gratitude for Mr. Kalani's contributions. Ms. Raje is also designated as a Key Managerial Personnel authorised to determine the materiality of events and make disclosures to stock exchanges.

Mastek Limited has officially submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2024-25. This action, dated August 29, 2025, complies with the mandate set forth by Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has clarified that the BRSR is an integrated part of its Annual Report for FY25, which was also submitted to the stock exchanges on the same date. Furthermore, Mastek has made the BRSR accessible on its corporate website for all stakeholders. This report is crucial for understanding the company's performance and commitment to environmental, social, and governance (ESG) principles, though the specific financial or strategic details within the BRSR are not elaborated in this submission notice. The filing represents a standard regulatory disclosure.

Mastek Limited, through a formal filing with the stock exchanges (BSE and NSE) on August 24, 2025, announced the allotment of 25,047 equity shares. These shares, each with a face value of Rs. 5, were issued under the company's existing Employee Stock Option Plans (ESOP) VI and VII, following the exercise of vested options by eligible employees. The allotment was approved by the Stakeholder Relationship Committee of the Board of Directors.

This issuance has resulted in an increase in Mastek's paid-up share capital. The capital has been revised from Rs. 15,47,48,350, which comprised 3,09,49,670 equity shares, to Rs. 15,48,73,585, representing a total of 3,09,74,717 equity shares. The net increase in paid-up capital is Rs. 1,25,235, corresponding to the face value of the newly allotted shares.

Crucially, the disclosure states that these 25,047 equity shares shall rank pari-passu with the company's currently outstanding equity shares in all respects, meaning they carry the same rights, including voting rights and dividend entitlement. The detailed annexure accompanying the filing provides specific information on the ESOP schemes, including dates of 'in-principle' listing approvals, the number of shares to be issued under each plan, and importantly, the exercise prices and the premiums paid per share by employees for exercising their options. For instance, some options were exercised at Rs. 5 with no premium, while others involved exercise prices ranging from Rs. 132 to Rs. 350 with corresponding premiums. This news pertains solely to share capital restructuring via ESOP and does not include any financial performance results, management guidance, or outlook updates for the company.